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ABSTRACT OF THE DISSERTATION
Cocaine Induces Apoptosis in Coronary Artery Endothelial Cells:
Cellular and Molecular Mechanisms

by

Jiale He

Doctor of Philosophy, Graduate Program in Pharmacology
Loma Linda University, June 2001
Dr. Lubo Zhang, Chairperson

Cocaine abuse has been associated with numerous cardiovascular consequences,
such as depressed myocardial contractility, elevated blood pressure, coronary artery
vasoconstriction, and myocardial ischemia and infarction. The multifactorial effects of
cocaine often contribute to its sympathomimetic function. However, the direct cytotoxic
effects of cocaine on the cardiovascular system, especially vascular endothelium, and the
cellular and molecular mechanisms remain unknown. The present study was designed to
examine the general hypothesis that cocaine induces apoptosis of coronary artery
endothelium by suppressing nitric oxide synthesis, stimulating cytochrome c release from
mitochondria and subsequently activation of the caspases cascade, which lead to
endothelial cell apoptosis. We found that cocaine induces apoptosis of endothelial cells in
a dose- and time-dependent manner. The induction of apoptosis by coaine is through the
activation of mitochondria-mediated apoptotic pathway. Cocaine-induced mitochondrial
cytochrome c release is via bax translocation and decrease of bel-2 level. The decrease of
NO production in endothelial cells exposed to cocaine may amplify the apoptotic signals.
The studies not only provide a mechanistic basis of endothelium damage in response to

xu

cocaine but also enhance our basic understanding of endothelial apoptosis in general and
improve our understanding of coronary ischemia, coronary atherosclerosis, and
myocardial ischemia and infarction from a new prospective.
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CHAPTER 1
INTRODUCTION
A. A Brief History
Coca leaves has been chewed by the Indians of Peru, Bolivia and Columbia for
more than 2,000 years (Kleber et ah, 1988). In the 1500s European explorers in South
America observed marked increase in endurance in coca-chewing Indians. However, the
pharmacological effects of cocaine remained unrealized until Carl Roller and William
Halsted described the local anesthetic properties of cocaine in the 1880s (Tokarski et al.,
1992). In the late 19th century, cocaine was widely available as a medication and also in
tonics and beverages (Kleber et al., 1988). The epidemic increase in cocaine abuse during
the last decade has focused public and scientific attention of unrestricted use of the drug.
It has been estimated that more than 23 million people in the United States have used
cocaine at some time. The number of frequent users (at least weekly) has remained steady
since 1991 at about 640,000 persons (Hardman et al., 1997).
B. Pharmacokinetics and Metabolism
CH3
/

N

cooc

Fig.l. Chemical structure of cocaine
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Cocaine is an ester of benzoic acid and a nitrogenous base which is a structure
fundamental to many local anesthetics (Hardman JG et al,1997). In its basic form, which
is the predominant form in the blood, cocaine passes across cell membranes quickly
(Benowitz et al., 1993). The half-life of cocaine averages 60-90min after intravenous
dose and may be substantially longer (up to 5 hr) after nasal dosing (Benowitz et al.,
1993). The LD50 for cocaine was 95.1mg/kg in mice (Bedford et al.,1982). Generally,
a-1-acid glycoprotein is the major plasma protein that binds to basic compounds.
Cocaine also binds to human albumin but with lower affinity (Sukbunthemg et al.,1996).
The in vivo values for unbound fraction of cocaine determined from authentic blood
samples taken from rats dosed intravenously with cocaine (10 mg/kg) ranged from 67 to
69% (over the concentration range 300-1500 ng/mL). The in vitro unbound fraction of
cocaine was in the range of 62 to 63% over the concentration range 75-2025 ng/ml
(Sukbunthemg et al.,1996).The peak plasma concentration of cocaine in human
volunteers ranged from 600 (Oral administration, 1250mg total daily dose) to 6000ng/ml
(IV administration, 2.95 mg/kg) (Benowitz, 1993; Jufer et al., 1998; Dow-Edwaeds et
al.,1996). In addition, a recent study demonstrated that repeated doses of cocaine
produced a dose-related accumulation in serum cocaine concentration and the cocaine
area under the curve (AUC) values reached 16000 ng-h/ml («50pM) in human volunteers
with total daily oral administration of 1600 mg cocaine (Jufer et al., 1998). It would be
expected that the plasma concentrations of cocaine in addictive drug abusers are higher
than in volunteers. Studies also suggested that the concentration of cocaine in active drug
abusers are often >100 pM (Nassogne et al., 1997). Considering unbound cocaine in
plasma is about 65%, the free cocaine concentration in plasma in active drug abusers may
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fit in the range from 30 to 65 (iM. In vitro, the effects of cocaine have been determined in
the range of 10'8 to 10'3 M in many studies (Chokshi et ah,1989; Jover et ah,1993; Renard
et ah, 1994; He et ah, 1994; Huang et ah, 1997; Mo et ah, 1998; Zhang et ah, 1998;
Wilbert-Lampen et ah, 1998; Diez-Femandez et ah, 1999; Boess et ah,2000; Tanhehco et
ah,2000; Zaragoza et ah, 2001). Cocaine is metabolized by plasma pseudocholinesterases
to yield ecgonine methyl ester and is hydrolized in the liver to yield benzoylecgonine,
both of which are excreted in the urine (Tokarski et ah, 1992). Cocaine is also
metabolized by the microsomal oxidative system to norcocaine, which is sequentially to
N-hydroxynorcocaine (Benowitz et ah, 1993). The metabolites of cocaine can be detected
in the serum for approximately 48 hours and in the urine for 2 to 3 days, although urine
metabolites may persist in high-dose cocaine abusers for up to 3 weeks (Weiss et
ah, 1988). The comparison of pharmacokinetics of cocaine among different species and
rountes are listed in table 1 (Dow-Edwards 1996).
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TABLE 1
PHARMACOKINETICS OF COCAINE:
COMPARISON OF SPECIES AND ROUTES OF ADMINISTRATION

Species Route Dose
(mg/kg)

Human

IV
IV
IV
IV
IV
IV
smoked
smoked
IN
IN
IN
IN
IN
IN
PO
PO
PO
MacaqueIM
Preg
IV
Sheep
smoked
smoked
SheepPreg
Rat

Peak Value Peak time Tl/2 Mat-fet
(min) ratio
(ng/ml)

0.23
0.44
0.46
0.6
1.47
2.95
0.4
0.67
0.23
0.91
1.37
2
2
2
2
2
2

221
250
308
550
1,000
6,000
225
160
53
115
206
350
170
160
290
242
209

1.0

288

2

20,000

1.3
1.5

IV
2
IV
2
IV
6
IV
7.5
IV
8
IV
10
IV chronic 7.5
smoked 0.26
smoked 1.54
IP
7.5
IP acute 7.5
IP
15
IP
30

350
902
7,900
11,432
1,000
1,757
610
2,000
1,970
95
205
130
2,242
230

610

<5 min
5 min
<5 min
10 min
<5 min
<5 min
10 min
5 min
60 min
30 min
30 min
70 min
90 min
60 min
80 min
65 min
60 min

1.2 hr

30 sec
<1 min
1.46
7.5 min
15 min
1.32 hr

1
5

45 sec
45 sec
15 min
10 min
15 min
60 min

4

Javid et al. 78
Evans et a. 95
Javid et al. 78
Jones 90
Barnett et al. 81
Barnett et al. 81
Jones 90
Evans et al. 95
Javid et al. 78
Javid et al. 78
Javid et al. 78
Jones 90
Wilkinson et al. 80
Van Dyke et al. 78
Jones 90
Wilkinson et al. 80
Van Dyke et al. 78

38
87

15 min
1 min
1 min
1 min

7

3.4

1.6

26

0.3 hr

1.9 hr
1.54
108
72

54

Source

Binienda et al. 93
Burchfield et al. 91a
Burchfield et al. 91a
Burchfield et al. 91a
Woods et al. 87
DeVane et al. 91
hrBoni et al. 91
Pan et al. 91
Nayak et al. 76
Boni et al. 91
Pan et al. 91
Boni et al. 91
Boni et al. 91
Lau et al. 91
Pan et al. 91
Lau et al. 91
Lau et al. 91

TABLE 1 (continued)
Species Route Dose
(mg/kg)
IP chronic 7.5
PO
7.5
PO
15
PO
30
SC
15
SC
20
SC
20
SC-chronic 20
SC-chronic 20
Rat-preg IV . .33/min
IV
3
IP
30
60
IG
IG
30
SC
40
Mouse
IP
10
IP
10
IP
25
MouseIP
10
Preg

Peak Value
(ng/ml)
4,242

130
150
250
240

490
494
500
502
1,660
3,725
2,000
5,400
1,000
3,000
380
2,000
7,000
300

Peak time Tl/2 Mat-fet Source
(min) ratio
Pan et al. 91
30 min
Lau et al. 91
45 min
90
Lau et al. 91
54
45 min
Lau et al. 91
96
30
Lau et al. 91
180 min
120
Nayak et al. 76
4 hr
1 hr
Mule & Misra 77
4 hr
Nayak et al. 76
1 hr
2 hr
1 hr
Mule & Misra 77
na
Morishima et al. 92
4.5
Mactutus et al. 94b
30 sec
<1
<30 min
DeVane et al. 89
46
15 min
1.8
Dow-Edwards 90
23
Dow-Edwards 90
44
1.4
15 min
2 hr
2.8
Spear et al. 89
Shah et al. 80
15 min
Benuck et al. 87
5 min
16
5 min
16
Benuck et al. 87
15 min

Shah et al. 80

KEY: IV = intravenous; IP = intraperitoneal; IM = intramuscular; SC = subcutaneous;
IG = intragastric; IN = intranasal; PO = oral; preg = pregnant. Mat-fet = matemal/fetal

C. Cardiovascular Effects of Action
Cocaine has multiple effects. A study suggested that the coronary artery is more
sensitive to endogenous vasoactive substances after chronic cocaine use (Jones et al.,
1990). Cocaine abuse has been reported to decrease coronary blood flow (Miao L,1996;),
cause coronary artery vasoconstriction (Vongpatanasin et al., 1997) recurrent coronary
vasoconstriction (Brogan WC et al., 1992), ventricular arrhythmias (Gamouras et al.,
2000) myocardial ischemia and infarction (Pitts et al., 1993) and even sudden cardiac
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death (Fraker et a/., 1990; Stambler et a/., 1993). The major effects of cocaine on
cardiovascular and CNS system are listed in Table 2.
D. Receptor Binding
Cocaine is known to bind to atypical (a) opioid receptors in the central nervous
system (Debonnel 1993). Subtypes of opioid receptors (8 and p) had been shown to
express on endothelial cells (Stefano et al.,1995; Vidal et al.,1998; Stefano et al.,1998).
A recent study showed cocaine (10‘7 to 10'4M) dose-dependently increased endothelin
release in endothelial cells that can be blocked by the nonselective a-receptor antagonists
haloperidol and the highly selective universal a-ligand ditolylguanidine (Wilbert-Lampen
et al.,1998). Combined with their binding study, Wilbert-Lampen et al. estimated that
there are about 1400 a-binding sites per endothelial cell. It appears that cocaine act as an
exogenous agonist at peripheral endothelial a-receptors (Wilbert-Lampen et al.,1998).
The blockade of a-receptors by the nonselective opioid receptor antagonist naloxone may
provide evidence for the effectivness in the therapy of cocaine intoxication.
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TABLE 2
CARDIOVASCULAR & CNS COMPLICATIONS OF COCAINE ABUSE
Cardiovascular
Hypertension
Intracranial hemorrhage
Aortic dissection/rupture
Arrhythmias
Sinus tachycardia
Supraventricular tachycardia
Ventricular tachyarrhythmias
Organ ischemia
Myocardial ischemia and infarction
Renal infarction
Intestinal infarction
Limb ischemia
Myocarditis
Shock
Sudden death
Central Nervous system
Headache
Seizures
Transient focal neurological deficts
Stroke
Subarachnoid hemorrhage
Intracranial hemorrhage
Cerebral infarction
Embolic(endocarditis)
Coma
Neurological complications

E. Apoptosis
a. Background
Cell death has long been recognized by biologists in the last century. There are
many ways for cells to die, but from cell biological point of view only two forms exist:
physiological and pathological cell death.
Pathological cell death, also called necrosis, occurs when cells are exposed to
extreme variant conditions such as hypothermia, hypoxia, complement or lytic viruses
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attack, which may result in direct damage to the plasma membrane. Necrosis begins with
an impairment of the cell’s ability to maintain homeostais, leading to an influx of water
and extracellular ions. Intracellular organelles, most notably the mitochondria, and the
entire cell swells and rupture. Due to the ultimate breakdown of the plasma membrane,
the cytoplasmic contents including lysosomal enzymes are released into the extracellular
fluid. Therefore, in vivo, necrotic cell death is often associated with extensive tissue
damage resulting in an intense inflammatory response (Van Furth et ah, 1988; Kerr et
ah,1972).
On the other hand, physiological cell death had long been overlooked until Wyllie
and Kerr discovered a similar morphology to be associated with atrophy of the adult liver
and concluded that cell death by “shrinkage necrosis” was responsible for the
disappearance of cells from the tissue in their model in 1971 (Kerr 1971). A year later
they introduced the word APOPTOSIS to indicate this form of cell death (Kerr et
ah, 1972). The term apoptosis is derived from the Greek apo “apart” and ptosis “fallen”,
meaning the shedding of leaves from trees during the autumn.
Apoptosis, in contrast to necrosis, is a mode of cell death that occurs under
normal physiological conditions and the cell is an active participant in its own demise
(cellular suicide). It refers to an innate physiological process by which the body removes
unwanted or damaged cells. Apoptosis most often found during cellular differentiation,
embryogenesis, tissue homeostasis, metamorphosis, cancer and induction and
maintenance of immune tolerance. It is now recognized that most, if not all, physiological
cell death occurs by apoptosis. Cells undergoing apoptosis show characteristic
morphological and biochemical features. These features include chromatin aggregation.
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degradation of chromatin, initially into large fragments of 50-300 kilobases and
subsequently into smaller fragments that are monomers and multimers of 200 bases
(Oberhammer et al., 1993; Wyllie, 1980), nuclear and cytoplasmic condensation,
shrinkage of the cell, membrane blebbing and breakdown of the cell into membranebound apoptotic bodies which contain ribosomes, morphologically intact mitochondria
and nuclear material. In vivo, these apoptotic bodies are rapidly recognized and
phagocytized by either macrophages or adjacent epithelial cells ( Savill et ah, 1989). The
whole process takes place only a few hours in vivo. Due to this efficient mechanism for
the removal of apoptotic cells in vivo no inflammatory response is elicited. In vitro, the
apoptotic bodies as well as the remaining cell fragments ultimately swell and finally lyse.
This terminal phase of in vitro cell death has been termed secondary necrosis. Another
charcteristic feature of apoptotis is the activation of a group of protease called caspases
which is orignially thought to be unique for apoptosis but recent studies showed that
certain caspases are also involved in necrosis (Casiano et al., 1998). The exact role of the
caspases in necrosis is not clear at present.
b. Apoptotic Signalling Pathways
In the 1990s’, Horvitz and coworkers opened the door towards molecular
mechanisms underlying the morphology of apoptosis with their work on the nematode C.
elegans (Ellis et al.,1991). Since then our knowledge about the apoptotic program has
increased rapidly and still is increasing every day. At present, several key players and
mechanisms of this process have been elucidated.
There are a wide diversity in molecular pathways controlling apoptosis depending
on the cell type and its external environment. Analysis of these pathways is complicated
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due to the fact that external stimuli may activate several signal transduction pathways
with opposing effects and certain intracellular signals often involved in the regulation of
apoptosis, cell proliferation or differentiation (Hale et ah, 1996). It is generally accepted
that the death receptor pathway and the mitochondria pathway are the two best
characterized apoptotic pathways. Figure 2 shows a shematic diagram of the two
pathways.
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Mitochondrion

Death Receptor

Activation of caspase cascade

I
Apoptosis

There are five death receptors that have been identified so far (Haunstetter et
al.,1998). The death receptors contain a distinct cytoplasmic domain (the death domain)
which is critical for proapoptotic functions. The death receptors and their ligands are
listed in Table 3. After binding of their ligands, the death receptors form a homotrimeric
complex, and by virtue of death domain-mediated protein-protein interactions, recruit
intracellular adaptor proteins to the cell membrane. Induction of apoptosis by death
receptors critically depends on caspases activation (Haunstetter et al.,1998).

TABLE 3
DEATH RECEPTORS AND THEIR LIGANDS
Ligand

Receptor

FasL

Fas
TNFR1

TNF-a

DR3

Apo-3L

DR4

TRAIL

DR5

TRAIL

Recently, the mitochondrion has been identified as playing a central role in
apoptosis. Many cells initiate apoptosis via the mitochondria pathway, (for review, see
Green et al.,1998). Mitochondria are the cell’s power sources. They are distinct
organelles with two membranes. Cytochrome c resides in the space between the outer
and inner membranes of mitochondria, where it connected to the cytochrome c oxidase
complex. It assists the respiratory chain to produce ATP by transport electrons from
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cytochrome c reductase (respiratory chain complexes III) to cytochrome c oxidase (
respiratory chain complexes IV). A crucial event of apoptosis is the formation of
channels in mitochondria outer membrane allowing the release of proapoptotic proteins
like cytochrome c and apoptosis-inducing factor (AIF). Once cytochrome c is released
from the mitochondrial intermembrane space, the cell is irreversibly commited to death.
Either apoptosis occurs through the activation of caspase cascade, or the cell goes
through a necrosis-like death due to the collapse of electron transport (Barinaga 1998;
Green et al.,1998). Cytochrome c can directly bind to apoptosis activationg factor-1
(Apaf-1) in the cytosol. This binding allows Apaf-1 to link up two caspase-9 precursors
together in the presence of dATP. The dimerization of two caspase-9 precursors forms
active caspase-9, which then activate caspase-3 precursor and activate the whole caspase
cascade, leading to cell death.
c. The Caspase Family
A key phenomenon of apoptotic cell death is the activation of a unique group of
proteases called caspases (for Cysteine-containing aspartate-specific proteases). Until
now, at least 10 members of caspases have been identified (Thomberry et al.,1998). Key
members and their prodomain, MW are listed in Table 4.
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TABLE 4
CASPASES
Nomenclature

Previous Nomenclature

Prodomain

MW(kD)

Caspase-1

ICE

Long

45

Caspase-2

ICH-1

Long

48

Short

32

Caspase-3

CPP32,Yama, Apopain

Caspase-4

TX, ICH-2, ICEREL-II

Long

43

Caspase-5

TY, ICEREL-III

Long

48

Caspase-6

Mch2

Short

34

Caspase-7

Mch3, ICE-LAP3, CMH-1

Short

35

Caspase-8

FLICE, Mach, Mch5

Long

55

Caspase-9

ICE-LAP3, Mch6

Long

46

Caspase-10

Mch4

Long

55

mCaspase-11*

ICH3

Long

42

Long

56
43

mCaspase-12 *
Caspase-13

ERICE

Long

Caspase-14

MICE

Short

* all mammalian caspases are of human origin except for murine caspase-11
and-12, for which no human counterparts have been identified yet.
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of different proteins, including nuclear proteins, proteins involved in signal transduction,
and cytoskeletal targets (Haunstetter et al.,1998). Most of these protein substrates appear
to be cleaved by caspase-3 and -7. However, lamin is selectively cleaved by caspase-6
(Takahashi et al.1996).
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Death Receptor
y

Caspase-8

Procaspase-2

>■ Caspase-2

Procaspase-9

>- Caspase-9

V

Procaspase-10 ---- >■ Caspase-10
Procaspase-3
Procaspase-7
Procaspase-6

^ Caspase-3
^ Caspase-7
^ Caspase-6

Cytochrome c

d. The Bcl-2 Family
Given the fact that the effector machinery for apoptosis is already in place in all
nucleated cells, it is not supprsing that mechanisms have evolved to allow for a tight
regulation of apoptosis. A close link between apoptosis and mitochondrial physiology is
suggested by the presecence of bcl-2 family proteins.The mammalian proto-oncogene
bcl-2 was first identified to be involved in most follicular lymphomas (B cell
lymphomas). To date a family of at least 15 bcl-2 homologous gene has been discovered
in mammals. Members of this family act either to prevent or to promote cell death in the
regulation of apoptosis (Adams et al.,1998). The bcl-2 family can be further divided into
three subfamilies: bcl-2, bax and BH3. The later two subfamilies are proapoptotic
whereas bcl-2 subfamily has antiapoptotic effects. The proteins of this family share a
structure homology characterized by the presence of regions termed BH (for Bel
Homology). Four different domains, BH1-4, can be recognized and each member bears
one or more different BH domains. These domains are involved in homo- and
heterodimerization of the bcl-2 like proteins (Adams et al.,1998). Although the exact
mechanisms of which the bcl-2 members regulate apoptosis are still not clear at present,
several competing hypotheses have been proposed. Three popular models are as follows:
1) bcl-2 members insert into the outer mitochondrial membrane where they form
channels which facilitate protein such as cytochrome c release. 2) bcl-2 members induce
rupture of the outer membrane. It is possible that bcl-2 members interact with
mitochondrial permeability transition pore (FTP) and induce its opening which may
cause the rupture of the outer membrane. 3) bcl-2 members interact with other proteins to
form channels. Heterodimerization between pro- and anti-apoptotic family members
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would inhibit apoptosis by preventing cytochrome c release (Hengartner 2000).
Modulating the expression of bcl-2 family members in the regulation of apoaptosis is an
attractive and promising therapeutic strategy.
F. Cocaine and Apoptosis
The multifactorial effects of cocaine often contribute to its sympathomimetic
function. However, the direct cytotoxic effects of cocaine on the coronary artery
endothelium are not clear. Recently, several animal experiments have demonstrated that
cocaine induces apoptosis in cultured neurons (Nassogne et a/., 1997), thymocyte (Wu et
al, 1997) and hepatocytes (Cascales et a/., 1994). Compelling evidence has accumulated
indicating that apoptotic cell death plays a critical role in a variety of cardiovascular
diseases, including myocardial ischemia and infarction, heart failure, and atherosclerosis
(Haunstetter and Izumo, 1998).
In many, if not all, apoptosis scenarios, there are opening of a large conductance
channel known as the mitochondrial permeability transition pore and collapse of the
mitochondria inner transmembrane potential, leading to the release of cytochrome c
(Green and Reed, 1998). Cytochrome c, with apoptosis activating factor-1 (Apaf-1)
activates caspase 9 that in turn activates caspase 3 (Thomberry et al.,1998). Cocaine
inhibits the activity of the terminal electron transport system of the mitochondria and
decreases mitochondrial membrane potential in cardiac myocytes (Fantel et al., 1990;
Yuan and Acosta, 1996). These studies suggest that cocaine-induced cytotoxicity is
mediated, at least in part, by its effect on mitochondria. However, whether or to what
extent mitochondrial release of cytochrome c contributes to cocaine-induced apoptosis in
coronary artery endothelial cells is unknown. Furthermore, the mechanisms regulating
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cytochrome c release remain unclear. Studies have suggested that Bax, a pro-apoptotic
member of the Bcl-2 gene family, can form specific mitochondrial transmembrane
channels large enough that allow the release of cytochrome c from mitochondria (Reed,
1997). On the other hand, overexpression of Bcl-2 effectively blocked the release of
cytochrome c (Yang et al, 1997; Kluck et al, 1997). It has been proposed that the ratio
of Bcl-2/Bax acts as a rheostat which regulates susceptibility to apoptosis (Korsmeyer et
a/., 1993). This rheostat can be reset in favor of apoptosis by repressing bcl-2 and
inducing bax expression (Miyashita et a/., 1994; Selvakumaran et al, 1994).
Studies suggest the endothelium-dependent vasorelaxation is impaired in long-term
cocaine users (Wang et al.,1995; Havranek EP et al., 1996). The inhibition of NO
generation from coronary endothelium results in increase in coronary vascular resistance
and attenuation of flow-induced coronary vascular dilation (Chu A et al., 1991). There is
also evidence that cocaine impairs peripheral endothelial nitric oxide (NO) synthesis (Mo
et a/., 1998). The inhibition of NO may further intensify the cocaine-induced left
ventricular dysfunction (Roig E et al., 2000). The effects of NO on apoptosis are highly
tissue specific. Studies have shown that NO donors or stimulation of NO synthase induce
apoptosis in a variety of different cell types (Fehsel et al, 1995; Wu-Hsieh et a/., 1998).
However, in endothelial cells, NO seems to have an anti-apoptotic effect (Ceneviva et
a/., 1998; Tzeng et a/., 1997), which probably act by inhibiting or delaying the release of
cytochrome c from mitochondria (Madesh M et a/., 1999; Li J et a/., 1999) and/or by
preventing the activation of caspases (Stefanelli C et al,1999; Li J et al, 1999). Yet, the
exact role of NO played in cocaine-induced apoptosis is unknown.
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The aim of this project was to examine the general hypothesis: cocaine induces
apoptosis of coronary artery endothelium by suppressing nitric oxide synthesis and
stimulating cytochrome c release from mitochondria and subsequently activating the
caspases cascade. To test this hypothesis, we proposed a series of experiments in human
and bovine coronary artery endothelial cells and published a series of papers in peer
reviewed journals.
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Abstract
The present study was designed to determine direct cytotoxic effect of cocaine on
human coronary artery endothelial cells (HCAECs). Cocaine treatment of cultured
HCAECs induced a time- and dose-dependent increase in apoptotic cell death in
HCAECs. Cocaine-induced surface exposure of phosphatidylserine in HCAECs was
seen as early as at 6 h. With prolonged treatment up to 72 h, cocaine (10 - 500 pM)
produced a dose-dependent increase in apoptosis in the cells. Corresponding DNA
fragmentation induced by cocaine was demonstrated in situ by TUNEL assay and by
electrophoresis of labeled DNA fragments, showing the characteristic apoptotic ladders.
Both caspase-9 (Z-LEHD-FMK) and caspase-3 (Ac-DEVD-CHO) inhibitors blocked
cocaine-induced apoptosis. In addition, cyclosporin A inhibited cocaine-induced
apoptosis in a concentration dependent manner with IC50 of 0.3 pM. The maximum of
62% inhibition was obtained with 3 pM cyclosporin A. Cocaine-induced apoptosis was
also blocked by naloxone and nifedipine in a dose-dependent manner. These findings
suggest that cocaine induces apoptosis in cultured HCAECs, which may be mediated by
opioid receptors. The release of cytochrome c from the mitochondria and its subsequent
activation of caspase-9 and caspase-3 may play a key role in cocaine-induced apoptosis.
Introduction
It has been estimated that more than 23 million people in the United States have
used cocaine at some time. The epidemic increase in cocaine abuse during the last
decade has focused public and scientific attention on the cardiovascular consequences of
unrestricted use of the drug. Experimental data have shown that cocaine administration
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depresses myocardial contractility, increases blood pressure, and induces coronary artery
vasoconstriction and myocardial ischemia (1,2,3,4).
The effect of cocaine on the cardiovascular system is multifactorial. Whereas the
cardiovascular effects of cocaine are often attributed to its potent pharmacological effects
as an indirect-acting sympathomimetic agent, direct cytotoxic effects of cocaine on the
cardiovascular system remain unclear. Recently, several animal experiments have
reported that cocaine can induce apoptosis in cultured myocytes (5), neurons (6),
thymocyte (7), and hepatocytes cells (8). Apoptosis is an active physiological process
that permits the removal of unwanted or damaged cells from the body through an intrinsic
cell-suicide program. Compelling evidence has accumulated indicating that apoptotic
cell death may also play a critical role in a variety of cardiovascular diseases, including
myocardial ischemia and infarction, heart failure, and atherosclerosis (9,10).
We have recently demonstrated that cocaine causes direct cytotoxic effect on fetal
rat heart and induces apoptosis in cultured fetal rat myocardial cells in a time- and dosedependent manner (5). Cocaine-induced apoptosis in fetal myocytes was characterized by
multiple morphological and biochemical features of typical apoptotic cell death. The
defining features of apoptotic cell death are characterized by morphological changes such
as membrane remodeling, DNA fragmentation, DNA condensation, cell shrinkage, and
formation of apoptotic bodies. Cocaine-induced apoptosis was also demonstrated in adult
rat heart (11). Repeated intraperitoneal and intravenous cocaine exposure in the rat has
been found to increase apoptotic cell death in the heart from 2% in control rats to 14% in
cocaine-treated rats. Contraction band necrosis was not found in either group.
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Little is known about the cytotoxic effects of cocaine on the endothelium. The
present study was designed to test the hypothesis that cocaine causes endothelial cell
injury by inducing apoptosis in cultured human coronary artery endothelial cells
(HCAECs). Cocaine-induced apoptosis was determined by examining apoptotic features
of cell and nucleus morphology and DNA fragmentation. Using cyclosporin A to block
cytochrome c release from the mitochondria, we examined the potential role for the
mitochondria in cocaine-mediated apoptosis in HCAECs. The involvement of
mitochondrial pathway was further examined by using the caspase 9 inhibitor. We also
examined the potential role of opioid receptors and intracellular calcium in cocaineinduced apoptosis in the coronary artery endothelial cells.
Methods
Materials. Human coronary artery endothelial cells (HCAECs), endothelial cell
growth medium with 5% fetal bovine serum (EGM-MV Bulletkit), and trypsin
reagentpack were purchased from Clonetics Co (Walkersville, MD). Cocaine, nifedipine,
naloxone, cyclosporin A, Annexin V kit, Streptavidin-Fluorescein Isothiocynate (SavFITC), Hoechst 33258, methyl green, and phosphate-buffer saline (PBS) were purchased
from Sigma (St. Louis, MO). Ac-DEVD-CHO, caspase-3 inhibitor, was from
Pharmingen (San Diego, CA). Z-LEHD-FMK, caspasse-9 inhibitor, was from Kamiya
Biomedical Company (Seattle, WA). Proteinase K, in situ cell death detection kit,
DNase-free RNase, DNase were from Boehringer Mannheim (Indianapolis, IN). SYBO
Gold was from Molecular Probes (Eugene, OR).
•
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Cell Culture. Third passage HCAECs were seeded at a density of 5,000/cm and
cultured in EGM-MV Bulletkit which contains endothelial cell basal medium 500 ml, 10
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jag/ml hEGF 0.5 ml, 50 mg/ml gentamicin and 50 fig/ml amphotericin-B 0.5 ml, 1 mg/ml
hydrocortisone 0.5 ml, 3 mg/ml bovine brain extract 2 ml, and fetal bovine serum (FBS)
25 ml. The cells were cultured at 37 °C in a humidified incubator with 5% CO2,95% air,
and were used for the experiments at the fifth and sixth passages of 80% confluence.
Twenty four hours before cocaine treatment, the medium was replaced by the serum-free
medium. Cells were then exposed to different doses of cocaine (10 to 500 pM) for
various time periods. The morphological changes of endothelial cells were examined by
phase-contrast and fluorescence microscopy.
Detection of cell surface plwsphatidylserine. Cell surface phosphatidylserine
was detected by phosphatidylserine-binding protein annexin V conjugated with
Streptavidin-Fluorescein Isothiocynate (FITC) using the commercially available Annexin
V kit (Sigma). Monolayers of HCAECs grown on coverslips were washed with cold
phosphate-buffer saline, and incubated with 100 pi annexin V incubation reagent (10x
binding buffer 10 pi, propidium iodide 0.5 pg/10 pi, annexin V conjugate 0.05 pg/1 pi,
distilled water 79 pi) per sample for 15 min at room temperature in the dark. Cells were
then washed with lx binding buffer and incubated with 100 pi lx binding buffer
containing FITC for 15 min at room temperature in the dark. After wash with lx binding
buffer the sample was examined immediately by fluorescence microscopy. The
combination of propidium iodide and annexin V conjugated with FITC in the kit allowed
for the differentiation between the early (annexin V-FITC positive) and late (annexin VFITC and propidium iodide positive) apoptotic cells, and viable cells (unstained).
DNA fragmentation on agarose gel. After treatments, cells were harvested and
lysed in a lysis buffer of 20 mM Tris (pH 8.0), 20 mM EDTA, 1% SDS containing 300
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p,g proteinase K at 55 °C for 60 min. Protein was removed by the addition of sodium
acetic acid and centrifugation. DNA was precipitated from the supernatant with the same
volume of isopropanol and centrifuged at 14,000 xg for 1 min. The pellet was washed by
70% ethanol for two times at 4 °C. DNA was dissolved in Tris-EDTA buffer containing
0.5 U DNase-free RNase A and incubated for 2 h at 37 °C. DNA (10 pg) was
electrophoresed at 70 V in a 1.8 % agarose gel in Tris-phosphate-EDTA buffer, stained
with SYBO Gold, and photographed with UV illumination. A 100-bp DNA ladder
molecular-weight marker was added to each gel as a reference for analysis of
intemucleosomal DNA fragmentation.
In situ TUNEL assay. In situ labeling of fragmented DNA was performed with
terminal deoxynucleotidyl transferase (Tdt) UTP nick end-labeling (TUNEL) with a
commercially available in situ cell death detection kit (Boehringer Mannheim) according
to the manufacturer’s instruction. In brief, monolayers of HCAECs grown on coverslips
were fixed with 4% paraformaldehyde solution for 30 min at room temperature, washed
with phosphate-buffer saline, and incubated with permeabilisation solution (0.1% Triton
X-100, 0.01% sodium citrate) for 7 min at room temperature. Apoptotic cells were
labeled with 50 pi TUNEL reaction mixture, and conjugated with alkaline phosphatase
(AP) by incubating them with 50 pi converter-AP for 30 min at 37 °C. After substrate
reaction, stained cells were analyzed under light microscope. The nuclei were counterstained with 0.5% methyl green for 2 min at room temperature. Negative control samples
for TUNEL staining lacked Tdt. Positive controls were performed by incubating fixed
and permeabilized cells with DNase lU/lOOpl mixture for 10 min at room temperature.
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Quantitative analysis of apoptotic cells. Fluorescent DNA-binding dyes were
commonly used to define nuclear chromatin morphology as a quantitative index of
apoptosis within a cell culture system (12,13). Cells grown on coverslips were washed
with phosphate-buffer saline and then fixed in methanol:acetic acid (3:1) at 4 °C for 5
min. After fixation, the cells were stained for 10 min with the fluorescent DNA-binding
dye Hoechst 33258 at 8 pg/ml, and nuclear morphology was examined by fluorescence
microscopy. Individual nuclei were visualized at x400 to distinguish the normal uniform
nuclear pattern from the characteristic condensed coalesced chromatin pattern of
apoptotic cells. To quantify apoptosis, 500 nuclei from random microscopic fields were
analyzed and the percentage of apoptotic cells was calculated as the number of apoptotic
cells/number of total cells x 100%. Each experiment was conducted in triplicate and
repeated three to four times.
Statistical Analysis. Data were presented as the mean ± S.E.M. Statistical
analysis was performed with one-way ANOVA followed by Newman-Keuls tests.
Values were considered statistically significant at P < 0.05.
Results
Effect of cocaine on apoptotic cell death in HCAECs. Fig. 1 shows cocaineinduced phosphatidylserine translocation from the inner to the outer leaflet of the plasma
membrane detected by the phosphatidylserine-binding protein annexin V conjugated with
FITC. Without membrane permeabilisation, no staining of control HCAECs was
observed. After treatment of the cells with cocaine (100 pM) for 6 h, binding of annexin
V-FITC to the surface of apoptotic HCAECs was observed (Fig. 1 A). No staining of the
apoptotic HCAECs with trypan blue was detected at this stage. In addition, propidium
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iodide failed to stain apoptotic HCAECs at 6 h treatment of cocaine (Fig. 1 A). After 24 h
treatment, propidium iodide penetrated the apoptotic cells and stain nuclear DNA,
producing a strong, yellow-red fluorescent signal (Fig. IB).
Fig. 2 shows representative cell morphological changes induced by cocaine.
Under control conditions, HCAECs morphology appears normal and cell density is
approaching confluence (Fig. 2A). After exposure to cocaine (100 pM for 24 h), the cells
exhibited the characteristic features of cell shrinkage, rounding and partial detachment,
and demonstrated the lobulated appearance of apoptotic cells (Fig. 2B). Assessment of
nuclear chromatin morphology by Hochest 33258 staining using fluorescence microscopy
indicated condensed, coalesced, and segmented nuclei induced by cocaine (Fig. 3). In
accordance, cocaine induced formation of oligonucleosome-sized fragments of DNA as
ladders of -200 bp on agarose gels in a time-dependent manner (Fig. 4). Cocaineinduced DNA fragmentation in HCAECs was also detected in situ by TUNEL assay. As
shown in Fig. 5, cocaine (100 pM for 24 h) increased the apoptotic nuclei identified by
terminal deoxy transferase labeling of 3’ DNA ends.
Quantification of cocaine-induced apoptotic nuclei defined by the fluorescent
DNA-binding dye Hochest 33258 indicated that cocaine induced apoptosis in HCAECs
in a time- and dose-dependent manner. Fig. 6 shows that cocaine time-dependently
induced apoptosis in HCAECs. At 24 h of incubation, cocaine (100 to 500 pM) produced
concentration-dependent increases in apoptotic cells in HCAECs (Fig. 7, lower panel).
Prolonged treatment (72 h) lowered the effective dose of cocaine to 10 pM (Fig. 7, upper
panel). The control level of apoptotic cells was also increased from 8.1 ± 0.6% to 26.1 ±
1.2%.
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Effect of cyclosporin A and caspase inhibitors on cocaine-induced apoptosis.
As shown in Fig. 8, cyclosporin A inhibited cocaine-induced apoptosis in HCAECs in a
dose dependent manner with pD2 of 6.54 ± 0.18. The maximum inhibition of 62% was
obtained at 3 pM cyclosporin A. However, higher dose of cyclosporin A (lOpM) itself
caused a significant increase of apoptotic cells compare with the control group (data not
shown), suggesting a toxic effect of cyclosporin A to HCAECs at higher doses. Both
caspase-3 (Ac-DEVD-CHO) and caspase-9 (Z-LEHD-FMK) inhibitors blocked cocaineinduced apoptosis in HCAECs (Fig. 9).
Effect of nifedipine and naloxone on cocaine-induced apoptosis. To elucidate
the role of calcium in cocaine-induced apoptosis, HCAECs were incubated concomitantly
with cocaine and various concentrations of nifedipine for 24 h. Fig. 10 shows that
nifedipine (0.1 to 10 pM) inhibited cocaine-induced apoptosis in a dose-dependant
manner (P < 0.05). Nifedipine (10 pM) did not have apoptotic effect on HCAECs but
completely blocked the cocaine-induced apoptosis (Fig. 10). In addition, naloxone dosedependently inhibited cocaine-induced apoptosis (Fig. 11, P < 0.05), suggesting an
involvement of opioid receptors in the cocaine-induced apoptosis in HCAECs.
Discussion
The present study has demonstrated for the first time that cocaine causes a direct
cytotoxic effect on cultured human coronary artery endothelial cells (HCAECs) and
induces apoptosis in HCAECs in a time- and dose-dependent manner. Our data suggest
that cocaine-induced apoptosis in HCAECs is mediated by opioid receptors and is
calcium dependent. In addition, the release of cytochrome c and its subsequent activation
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of caspase 9 and caspase 3 are likely to play a key role in cocaine-induced apoptosis in
HCAECs.
The finding of annexin V-FITC binding to HCAECs after 6 h treatment of the
cells with cocaine (Fig. 1 A) suggests that cocaine induces apoptosis in HCAECs as early
as at 6 h. In normal cells, the restriction of membrane lipid phosphatidylserine to the
inner leaflet of the plasma membrane precludes the binding of phosphatidylserine
binding proteins to healthy cells. Phosphatidylserine extemalization occurs rapidly after
apoptosis and precedes other morphological changes such as “leaky” plasma membrane,
nuclear breakdown, and chromosomal fragmentation. As a consequence, the
phosphatidylserine-binding protein annexin V is able to bind to the apoptotic cells. It has
been demonstrated that annexin V-FITC binding is a specific and sensitive method to
identify early stage of apoptosis (14,15,16). As reported in many other cells (14,15,16),
annexin V binding preceded the loss of membrane integrity in apoptotic cells induced by
cocaine in the present study. This conclusion is supported by the finding that propidium
iodide failed to stain apoptotic HCAECs at 6 hr (Fig. 1 A). In addition, no staining of the
apoptotic HCAECs with trypan blue was detected at this stage. Because
phosphatidylserine is a potent surface procoagulant, a recent study demonstrated that
human endothelial cells with phosphatidylserine extemalization during apoptosis were
markedly procoagulant (14). This procoagulant effect was entirely abolished by annexin
V, confirming that it was phosphatidylserine-dependent. This finding suggests that
cocaine-induced phosphatidylserine extemalization in HCAECs may cause pathological
intravascular coagulation events and impair coronary circulation, which may explain in
part cocaine-induced myocardial ischemia and infarction. The finding of propidium
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iodide staining after 24 hr incubation of cocaine (Fig. IB) suggests that the plasma
membrane becomes increasingly permeable during the later stages of apoptosis in
HCAECs.
In the present study, cocaine-induced apoptosis in HCAECs was also clearly
demonstrated by morphological changes such as cell shrinkage and rounding,
characteristic features of apoptotic death. Moreover, simultaneous assessment of nuclear
chromatin morphology verified that these cells eventually manifested typical apoptotic
condensed and fragmented nuclei. In addition, we have confirmed that the process of
apoptosis defined on the basis of cellular and nuclear chromatin morphology correlates
with apoptosis defined on the basis of intemucleosomal DNA fragmentation assessed by
in situ labeling and gel electrophoresis. Similar findings of cocaine-induced apoptosis
have been reported in fetal rat myocytes (5), mice hepatocytes (8) and fetal mice cortical
neurons (6). Apoptosis in endothelial cells has been demonstrated with various factors
such as oxidized low density lipoprotein (13,17,18), ATP and adenosine (19),
lipopolysaccharide (12), and glucose (20). The present finding of the maximum of 23%
apoptotic cells induced by cocaine is in agreement with the previous studies showing that
18% to 21% of human umbilical vein and coronary artery endothelial cells, respectively,
became apoptotic in the presence of the maximal dose of oxidized low density lipoprotein
(13,18). In the light of that serum levels of cocaine in active drug abusers are often over
100 pM (6), the finding that cocaine can induce apoptosis in HCAECs at concentrations
as low as 10 pM in the present study fully warrants its physiological relevance. Whereas
the half life of cocaine in the serum ranges from 1 h (intravenous dosing) to 5 h (nasal
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dosing), the repeated uses of cocaine in active drug abusers produces dose-related
increases in serum cocaine concentrations (21,22).
The mechanisms underlying cocaine-induced apoptosis in HCAECs are not clear
at present. It has been demonstrated that cocaine activates immediate early genes such as
c-fos, c-jun, and zif/268 (23) that have been implicated in certain forms of apoptosis (9).
The present finding that cocaine-induced apoptosis was blocked by nifedipine suggests
that calcium influx plays a key role in cocaine-induced apoptosis in HCAECs. A similar
finding was observed in human umbilical vein endothelial cells in which oxidized low
density lipoprotein-induced apoptosis was mediated by calcium influx (17). Whereas
early evidence suggested that the endogenous endonuclease implicated in apoptosis in
most model systems is calcium-dependent (24,25,26), recent studies have demonstrated
that molecular targets for calcium include signal transduction intermediates,
endonuclease and proteases, and the enzymes involved in the maintenance of
phospholipid asymmetry in the plasma membrane (27). Moreover, it has been shown that
calcium inhibits Bcl-2 protein activity (28), induces a switch from low- to highconductance state of mitochondria permeability transition pore (29), and activates
caspase 3 activity (30).
In many, if not all, apoptosis scenarios, there is an opening of the mitochondrial
permeability transition pore leading to collapse of the mitochondria inner transmembrane
potential and the release of cytochrome c (31). It has been demonstrated that cocaine
increases intracellular calcium (32,33,34) and impairs mitochondrial function by
dissipating mitochondria membrane potential (32,35,36). The present finding that
cyclosporin A dose dependently inhibited cocaine-induced apoptosis in HCAECs
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suggests that release of cytochrome c from the mitochondria plays a key role in cocaineinduced apoptosis in human coronary artery endothelial cells. It has been well
documented that cyclosporin A prevents cytochrome c release by stabilizing the
mitochondrial transmembrane potential, and inhibits apoptosis (31,37,38,39). In the
present study, we have demonstrated that cyclosporin A inhibits cocaine-induced
apoptosis in HCAECs in a dose-dependent manner with IC50 of 0.3 pM. This finding is
consistent with our previous study in which we have demonstrated that cocaine-induced
cytochrome c release and apoptosis in myocytes are inhibited by cyclosporine A (5).
Similar findings were also obtained in human endothelial cells in which cyclosporin A
dose dependently inhibited oxLDL-induced cytochrome c release and apoptosis (39). In
contrast to the previous finding (39), present studies demonstrated that high concentration
of cyclosporin A (10 pM) itself induced apoptosis in HCAECs. Similar findings were
demonstrated in other cells (40,41). The genotoxic properties of cyclosporine have been
documented (42,43,44). The possibility that cyclosporin A inhibits the cocaine-induced
apoptosis by its interference at the level of the cell cycle remains elusive.
The notion that cocaine-induced apoptosis in HCAECs may involve release of
cytochrome c from the mitochondria has been further supported by the studies of caspase
inhibitors on cocaine-induced apoptosis. It has been well documented that caspase
cascade includes both initiator caspases and effector caspases (31,45,46). Proapoptotic
signals activate an initiator caspase that, in turn, activates effector caspases such as
caspase 3 leading to apoptotic cell death. Two initiator caspases, caspase 8 and caspase
9, mediate distinct sets of death signals. Caspase 8 is associated with apoptosis involving
death receptors that are activated by ligands of tumor necrosis factor gene superfamily
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(45). In contrast, caspase 9 is involved in death induced by cytotoxic agents, and is
activated by cytochrome c and Apaf-1 (31,46). In the present study, we have
demonstrated that cocaine-induced apoptosis in HCAECs is blocked by caspase 9 and
caspase 3 inhibitors, respectively. This finding re-enforces the notion that cocaineinduced apoptosis in HCAECs is mediated by the mitochondrial pathway.
In summary, we have shown that cocaine induces a time- and dose-dependent
increase in apoptosis in cultured human coronary artery endothelial cells. Cocaineinduced apoptosis in HCAECs is calcium-dependent and is likely to be mediated by the
release of cytochrome c and subsequent activation of caspase 9 and caspase 3. Increased
apoptosis of endothelial cells in coronary artery results in endothelial dysfunction, which
is likely to play a key role in cocaine-induced coronary artery vasoconstriction leading to
myocardial ischemia and infarction. In addition, apoptosis has been proposed as a means
of presenting otherwise sequestered antigens to the immune system (47,48). As a
consequence, autoantibodies could bind to apoptotic cells and trigger an inflammatory
response that damages surrounding healthy tissues.
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Figure 1. Cocaine-induced phosphatidylserine translocation in human coronary
artery endothelial cells (HCAECs). HCAECs were labeled with annexin V-FITC
(green) and propidium iodide (red) and photographed with fluorescence microscopy
(original magnification, x400) as described in the Methods. Panel A shows the binding
of annexin V-FITC to phosphatidylserine (shown in green) at the cell surface of HCAECs
treated with cocaine (100 pM) for 6 h. Panel B shows the double staining of
phosphatidylserine with annexin V-FITC (green) and nuclei with propidium iodide
(yellow-red) in HCAECs treated with cocaine for 24 h. Similar results were obtained
from two additional separated experiments.
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Figure 2. Cocaine-induced cell morphological changes in human coronary artery
endothelial cells (HCAECs). Cell morphology of HCAECs was examined by phasecontrast microscopy (original magnification, x200) in the absence (panel A) and presence
(panel B) of cocaine (100 pM, 24 h). The arrows show shrunken and rounded cells after
cocaine treatment. Similar results were obtained from five additional separated
experiments.
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Figure 4. Cocaine-induced oligonucleosomal DNA fragmentation on agarose gel in
human coronary artery endothelial cells (HCAECs). Cocaine (100 jaM)-induced
DNA fragments in HCAECs were separated on 1.8% agarose gels and stained by SYBOGold as described in the Methods. Control cells show no DNA ladders {lane C). Typical
apoptotic DNA ladders were shown at 24 h and 48 h incubation with cocaine {lanes 24
and 48). At 72 h, cocaine-induced DNA fragmentation showed a smear on agarose gel
{lane 72). Low (right) and high (left) DNA molecular-weight markers are shown in lane
M. The same results were obtained from two additional separated experiments.
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Figure 5. In situ detection of cocaine-induced DNA fragmentation in human
coronary artery endothelial cells (HCAECs). In situ detection of DNA fragmentation
in HCAECs was performed with the In Situ Cell Death Detection Kit (Boehringer
Mannheim) as described in the Methods. Cells were counter-stained with methyl green.
Apoptotic nuclei were shown as dark blue. Panel A shows the negative control of
HCAECs in the absence of terminal deoxynucleotidyl transferase. Panel B shows the
positive control of HCAECs treated with DNase. Panel C shows the control cells in the
absence of cocaine. Panel D shows the cells treated with cocaine (100 pM, 24 h).
Original magnification, x200. Similar results were obtained from two additional
separated experiments.
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Figure 6. Cocaine-induced time-dependent increases in apoptosis in human
coronary artery endothelial cells (HCAECs). HCAECs were incubated with cocaine
(300 pM) for the indicated times. Number of apoptotic cells was determined by Hoechst
33258 fluorescence-stained nuclei as described in the Methods, and expressed as percent
of the total cells. Data are means ± S.E.M. for four experiments. * P<0.05 vs. the control.
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Figure 7. Cocaine-induced concentration-dependent increases of apoptotic cells in
human coronary artery endothelial cells (HCAECs). HCAECs were incubated in the
absence (control, C) and presence of indicated concentrations of cocaine for 24 h (lower
panel) and 72 h (upper panel). Number of apoptotic cells was determined by Hoechst
33258 fluorescence-stained nuclei as described in the Methods, and expressed as percent
of the total cells. Data are means ± S.E.M. for four experiments. * P<0.05 vs. the
control.
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Figure 8. Inhibition of cocaine-induced apoptosis by cyclosporin A in human
coronary artery endothelial cells (HCAECs). HCAECs were incubated with cocaine
(100 pM, 24 h) in the absence or presence of increasing concentrations of cyclosporin A.
Number of apoptotic cells was determined by Hoechst 33258 fluorescence-stained nuclei
as described in the Methods. Data are means ± S.E.M. for four experiments.
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Figure 9. Effect of caspase inhibitors on cocaine-induced apoptosis in human
coronary artery endothelial cells (HCAECs). HCAECs were induced with cocaine
(100 pM, 24 h) in the absence and presence of caspase 9 inhibitor, Z-LEHD-FMK (ZLEHD, 20 pM), and caspase 3 inhibitor, Ac-DEVD-CHO (Ac-DEVD, 100 pM). Number
of apoptotic cells was determined by Hoechst 33258 fluorescence-stained nuclei as
described in the Methods, and expressed as percent of the total cells. Data are means ±
S.E.M. for four experiments. * /? < 0.05 vs. the control,
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p < 0.05 vs. cocaine alone.
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Figure 10. Effect of nifedipine on cocaine-induced apoptosis in human coronary
artery endothelial cells (HCAECs). HCAECs were induced with cocaine (Coe, 100
pM, 24 h) in the absence and presence of increasing doses of nifedipine (Nif). Number of
apoptotic cells was determined by Hoechst 33258 fluorescence-stained nuclei as
described in the Methods, and expressed as percent of the total cells. Data are means ±
S.E.M. for four experiments. * p< 0.05 vs. the control (C), + p< 0.05 vs. cocaine alone.
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Figure 11. Effect of naloxone on cocaine-induced apoptosis in human coronary
artery endothelial cells (HCAECs). HCAECs were induced with cocaine (Coc, 100
jiM,

24 h) in the absence and presence of increasing doses of naloxone (NLX). Number

of apoptotic cells was determined by Hoechst 33258 fluorescence-stained nuclei as
described in the Methods, and expressed as percent of the total cells. Data are means ±
S.E.M. for four experiments. One-way ANOVA analysis indicates that naloxone doesdependently inhibits cocaine-induced apoptosis {p < 0.05). Newman-Keuls post tests
reveal that only 100 pM naloxone significantly inhibits cocaine-induced apoptosis. * /? <
0.05 vs. the control (C), + p< 0.05 vs. cocaine alone.
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CHAPTER 3
ROLE OF MITOCHONDRIAL CYTOCHROME C IN COCAINE-INDUCED
APOPTOSIS IN CORONARY ARTERY ENDOTHELIAL CELLS

Jiale He, Yuihui Xiao, Carlos A. Casiano, Lubo Zhang

This chapter appeared in publication in the Journal of Pharmacology & Experimental
Therapeutics 295(3): 896-903
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Abstract
Cocaine induces apoptosis in coronary artery endothelial cells. Yet the cellular
and molecular mechanisms are not clear. Given that cocaine has profound toxic effects on
the mitochondria, the present study examined the role of mitochondrial cytochrome c in
cocaine-mediated apoptosis. Using cultured bovine coronary artery endothelial cells, we
found that cocaine-induced apoptosis was dose-dependently inhibited by cyclosporin A
with IC50 of 0.2 pM.

The maximum of 65% inhibition was obtained with 3 pM

cyclosporin A. Cocaine induced a translocation of cytochrome c from the mitochondria
to the cytosol with a 1.8-fold increase in cytosolic cytochrome c levels, and a
corresponding decrease in mitochondrial cytochrome c. In accordance with its inhibition
of cocaine-induced apoptosis, cyclosporin A blocked cocaine-induced cytochrome c
translocation. Correspondingly, cocaine-induced activation of caspase-9 preceded that of
caspase-3.

Caspase-8 was not activated.

Cocaine also produced a dose-dependent

decrease in Bcl-2 protein levels, but had no effect on Bax protein levels. The cocaineinduced decrease in the Bcl-2 protein was not affected by cyclosporin A but was partially
blocked by caspase-3 inhibitor Ac-DEVD-CHO. Collectively, these data indicate that the
release of cytochrome c from the mitochondria and the subsequent activation of caspase9 and caspase-3 play a key role in cocaine-induced apoptosis in these cells. Furthermore,
the down-regulation of the Bcl-2 protein may play an important role in cocaine-induced
release of cytochrome c.
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Introduction
Cocaine causes coronary artery vasoconstriction and myocardial ischemia and
infarction (Fraker et al., 1990; Stambler et ah, 1993). Whereas the multifactorial effects
of cocaine on the cardiovascular system often contribute to its sympathomimetic
function, we have recently demonstrated that cocaine induces apoptotic cell death in
human coronary artery endothelial cells (He et al., 2000). The apoptosis of endothelium
has been implicated in the processes of endothelial denudation, angiogenesis, thrombosis,
and atherosclerosis (Haunstetter and Izumo, 1998; Maclellan and Schneider, 1997).
Cocaine-induced apoptosis of coronary artery endothelial cells was characterized by
multiple morphological and biochemical features which were of typical apoptotic cell
death. However, the cellular and molecular mechanisms underlying cocaine-induced
apoptosis in coronary artery endothelial cells are not clear.
The signaling pathways leading to apoptosis involve the sequential activation of
cysteine proteases known as caspases, resulting in protein cleavage and breakdown of
DNA molecules. It has been well documented that caspase cascade involved in apoptosis
includes both initiator caspases and effector caspases (Thomberry and Lazebnik, 1998).
Pro-apoptotic signals activate an initiator caspase that, in turn, activates effector caspases,
e.g. caspase-3, leading to apoptotic cell death. Two initiator caspases, caspase-8 and
caspase-9, mediate distinct sets of death signals. Caspase-8 is activated by the death
signals that bind to death receptors located on cell surfaces (Ashkenazi & Dixit, 1998).
The ligands that bind to death receptors belong to the tumor necrosis factor gene
superfamily. In contrast, caspase-9 is involved in death induced by cytotoxic agents that
usually do not bind to the death receptors. Instead, they affect mitochondria and cause
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release of cytochrome c, which through interaction with APAF-1 activates caspase-9
(Green and Reed, 1998; Zou et ah, 1999). The regulatory mechanisms of cytochrome c
release are not fully understood, and are likely to vary with apoptotic stimuli and cell
types.

It has been known that anti-apoptotic members of the Bcl-2 family block

cytochrome c release, whereas pro-apoptotic member Bax promotes it (Jurgensmeier et
al., 1998; Kluck et al., 1997; Rosse et al., 1998; Yang et al., 1997). The expression of
Bcl-2 and Bax proteins has been shown to be under physiological and pathophysiological
modulation (Cook et al., 1999).
Although the mitochondrial/cytochrome c death pathway mediates apoptosis in
response to many stimuli, its involvement in cocaine-induced apoptosis of endothelial
cells has not been demonstrated. Given that cocaine has profound effects on the
mitochondria and decreases mitochondrial membrane potential (Fantel et al., 1990; Yuan
and Acosta, 1996), the present study was designed to test the hypothesis that cocaine
activates mitochondria-mediated apoptotic pathway in bovine coronary artery endothelial
cells. The specific objectives of this study were to determine: 1) if cocaine induced
translocation of cytochrome c from the mitochondria to the cytosol, 2) the time courses of
cocaine-mediated activation of caspase-9, caspase-8, and caspase-3, and 3) the effect of
cocaine on Bcl-2 and Bax protein expression. To demonstrate whether Bcl-2 and Bax are
upstream signals to mitochondrial/cytochrome c, we also determined if cyclosporin A,
which inhibits cytochrome c release, inhibited cocaine-induced changes in Bcl-2 and/or
Bax proteins in the present study.
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Materials and Methods
Materials. Hoechst 33258, cocaine, cyclosporin A, phosphate-buffer saline
(PBS), Annexin V-Cy3 apoptosis detection kit and anti-actin antibody were purchased
from Sigma (St Louis, MO). Fetal bovine serum was purchased from Hyclone
Laboratories (Logan, UT). Protein assay was from Bio-Rad (Hercules, CA). Purified
anti-Bax and anti-cytochrome c antibodies and Ac-DEVD-CHO were from Pharmingen
(San Diego, CA). Anti-Bcl-2 antibody was from Santa Cruz Biotechnology, Inc. (Santa
Cruz, CA). Horseradish peroxidase (HRP)-conjugated anti-mouse IgG was from
Amersham Life Science (Clearbrook, IL). Prestained protein molecular weight standards
was from GibcoBRL (Grand Island, NY). Caspase-3, 8, and 9 colorimetric assay kits
were from R&D Systems Inc. (Minneapolis, MN).
Cell Culture. Bovine coronary artery endothelial cells (BCAECs) were obtained
from Cell Applications, Inc. (San Diego, CA). Cells were grown in the complete medium
of Dulbecco’s Modified Eagle’s Medium (DMEM, Mediatech Cellgro Inc., VA) with
glucose (4.5 g/L), 15% fetal bovine serum, 100 U/ml penicillin, 100 pg/ml streptomycin,
and were incubated at 37 °C in a humidified incubator with 5% CO2,95% air. Cells were
used for the experiments at the fifth and sixth passages at 80% confluence. Twenty four
hours before cocaine treatment, the medium was replaced with serum-free medium. Cell
numbers were determined using a hemacytometer and cell viability determined using
trypan blue exclusion.
Phosphatidylserine Translocation. Phosphatidylserine translocation from the
inner to the outer leaflet of the plasma membrane is one of the early apoptotic features.
Cell surface phosphatidylserine was detected by phosphatidylserine-binding protein
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Annexin V conjugated with Cy3.18 using the commercially available Annexin V-Cy3
apoptosis detection kit (Sigma). Briefly, monolayers of BCAECs grown on coverslips
were washed with cold phosphate-buffer saline, and incubated with 50 pi double label
staining solution (containing 1 pg/ml AnnCy3 and 100 pmol/L 6-carboxyfluorescein
diacetate) for 10 min at room temperature in the dark. Cells were then washed with lx
binding buffer followed immediately by observation using a fluorescence microscope.
The combination of 6-carboxyfluorescein diacetate (6-CFDA) with Annexin V
conjugated with Cy3 in the kit allowed for the differentiation among live cells (green),
necrotic cells (red) and apoptotic cells (red and green).
Quantitative Analysis of Apoptotic Cells.

Fluorescent DNA-binding dye

Hoechst 33258 was used to define nuclear chromatin morphology as a quantitative index
of apoptosis as described previously (Harada-Shiba et ah, 1998; He et ah, 2000). Briefly,
cells were fixed by methanol/acetic acid (v/v 3:1) at 4 °C for 5 min and stained with
Hoechst 33258 for 10 min at room temperature. After mounting, the morphological
changes of the nuclei of apoptotic cells were visualized by fluorescent microscopy. The
number of apoptotic cells was counted in 9 randomly selected high power fields under a
fluorescent microscope (approximately 500 cells/cover slide).

The percentage of

apoptotic cells was calculated as the number of apoptotic cells/number of total cells x
100%. Each experiment was conducted in triplicate and repeated three to four times.
Western Blot Analysis. Bovine coronary artery endothelial cells were harvested
after treatments, and homogenized in ice-cold lysis buffer (20 mmol/L HEPES, pH 7.5,
10 mmol/L KC1, 1.5 mmol/L MgCb, 1 mmol/L EDTA, 1 mmol/L EGTA, 1 mmol/L
DTT, 1 mmol/L PMSF, 2 pg/ml aprotinin, 10 pg/ml leupeptin) for 30 min. To detect
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cytochrome c, proteins in cytosolic and mitochondrial fractions were separated as
previously described (Xiao et al., 1999). Total protein was used to detect Bax and Bcl-2
expression. Protein content was determined using a standard colorimetric protein assay
(Bio-Rad). The proteins were separated by 15% (cytochrome c) and 12% (Bax, Bcl-2)
SDS-polyacrylamide gels, respectively. They were then transferred to nitrocellulose
membranes, and incubated with primary antibodies against Bax (1:250), Bcl-2 (1:2000),
and cytochrome c (1:500), respectively in TBS-T buffer containing 4% nonfat milk.
After washing, the membranes were incubated with HRP-conjugated anti-mouse IgG
(1:2000), and visualized using an enhanced chemiluminescence detection system
(Amersham). Results were quantified using a scanning densitometer (model 670, BioRad). The data were normalized by actin and presented as the percentage of the control
protein levels within each group.
Caspase Activity Assay. Activities of caspase-3, caspase-8, caspase-9 were
determined using the corresponding caspase activity detection kits (R&D Systems).
Briefly, 100 pg total cell protein was added to 50 pi reaction buffer and 5 pi substrates of
DEVD-pNA, lETD-pNA, and LEHD-pNA, respectively. Samples were incubated at 37
°C for 8 h and the enzyme-catalyzed release of/?NA was quantified at 405 nm using a
microtiter plate reader. At each time point of study, the values of cocaine treated samples
were normalized to corresponding untreated controls allowing determination of the fold
increase in caspase activity.
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Statistical Analysis. Data were presented as the mean ± SEM. Statistical
analyses were performed by one-way ANOVA followed by Newman-Keuls post tests.
Differences were considered significant at P < 0.05.
Results
Cocaine-induced apoptosis. Fig. 1 shows cocaine-induced phosphatidylserine
translocation from the inner to the outer leaflet in the plasma membrane detected by the
phosphatidylserine-binding protein Annexin V conjugated with Cy3.

Using double

fluorescence staining with Annexin V Cy3 and 6-carboxyfluorescein diacetate (6-CFDA)
allowed us to differentiate among live, apoptotic and necrotic cells. As shown in Fig. 1,
control live cells show staining only with 6-CFDA (green, Fig. 1A). Treatment with
cocaine (100 pM for 48 h) increased the number of cells double-stained with Annexin V
Cy3 (cell membrane) and 6-CFDA (red and green, Fig. IB) suggesting that these cells
were undergoing apoptotic cell death.

The apparent yellow fluorescence in Fig. IB

resulted from a summing of red and green fluorescence. Some cells were only stained
with Annexin V Cy3 (red, Fig. 1C) suggesting necrotic cell death or post-apoptotic
necrosis.
Assessment of nuclear chromatin morphology by DNA-binding dye Hoechst
33258 staining using fluorescence microscopy showed condensed, coalesced, and
segmented nuclei induced by cocaine (Fig. 2). As shown in Fig. 3, quantification of
cocaine-induced apoptotic nuclei defined by Hoechst 33258 indicated that cocaine
induced a dose-dependent increase in apoptotic cells with EC50 of 50 pM. The maximum
of 27% apoptotic cells was obtained. In accordance, cell viability determined by trypan
blue decreased in a dose-dependent manner (Fig. 3).
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Cocaine-induced cytochrome c release. To reveal the potential role for
cytochrome c in cocaine-induced apoptosis in BCAECs, we first examined the effect of
cyclosporin A, which inhibits cytochrome c release from the mitochondria, on cocaineinduced apoptosis. As shown in Fig. 4, cyclosporin A inhibited cocaine-induced
apoptosis in a dose-dependant manner with pD2 of 6.67 ± 0.03. The maximal inhibition
of 65% was obtained at 3 pM cyclosporin A.
The inhibitory effect of cyclosporin A suggested that release of cytochrome c
from the mitochondria may play an important role in cocaine-induced apoptosis in
BCAECs. To further test this hypothesis, we examined directly the effect of cocaine on
cytochrome c translocation from the mitochondria to the cytosol in BCAECs by Western
blotting. The representative Western immunoblot showed that the monoclonal antibody
for cytochrome c detected a single band at expected size of 15 kDa (Fig. 5, upper panel).
After cocaine treatment, there was an increase in cytochrome c levels in the cytosolic
fraction and an accordant decrease in cytochrome c levels in the mitochondrial fraction
(Fig. 5, upper panel).

Quantitative densitometry for four independent experiments

revealed that cocaine increased cytosolic cytochrome c levels by 1.8-fold and decreased
mitochondrial cytochrome c levels by 80% (Fig. 5, lower panel). As also shown in Fig.
5, cyclosporin A (1 pM) inhibited the cocaine-induced translocation of cytochrome c in
BCAECs.
Cocaine-induced caspase activity. To further support the role of cytochrome c
and its subsequent activation of the caspase cascade in cocaine-induced apoptosis in
BCAECs, we determined the time courses of cocaine-induced activation of the protease
activities of caspase-9, caspase-8, and caspase-3. As shown in Fig. 6, after cocaine
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treatment caspase-9 activity was increased first and reached the maximum at 6 h and
continued up to 12 h. At 24 h, caspase-9 activity returned to the control levels. Caspase3 activity gradually increased in the first 24 h and reached its peak at 48 h. In contrast,
caspase-8 activity did not change significantly during the time period of study.
Effect of cocaine on Bax and Bcl-2 protein expression.

In an attempt to

understand the mechanisms underlying cocaine-induced cytochrome c release, we
determined the effect of cocaine on Bax and Bcl-2 protein levels by Western blot
analysis. As shown in Fig. 7, the representative Western immunoblot showed that the
monoclonal antibody for the Bcl-2 protein detected a single band at expected size of 29
kDa (Fig. 7, upper panel). Cocaine (30 and 100 pM, 48 h) produced a dose-dependent
decrease in Bcl-2 protein levels.

Quantitative densitometry for five independent

experiments revealed that cocaine produced more than 50% decrease in Bcl-2 protein
levels in BCAECs (Fig. 7, lower panel). As shown in Fig. 7, cyclosporin A (1 pM),
which inhibited cocaine-induced translocation of cytochrome c and apoptosis in
BCAECs, had no effect on cocaine-induced decrease in the Bcl-2 protein, suggesting that
reduction of the Bcl-2 protein was an up-stream event of cytochrome c release induced by
cocaine. Because Bcl-2 can undergo cleavage by activated caspases, we examined the
effect of caspase-3 inhibitor Ac-DEVD-CHO on cocaine-induced reduction of Bcl-2
protein levels. As shown in Fig. 8, cocaine-induced decrease in the Bcl-2 protein was
partially blocked by Ac-DEVD-CHO.

The expression of the Bax protein was also

detected in BCAECs and showed a significantly lower level than that of Bcl-2 (Bcl2/Bax: 7.5 ± 2.4).

In contrast to Bcl-2, cocaine treatment did not change Bax protein

levels in BCAECs (Fig. 9).

79

Discussion
The present study has demonstrated that cocaine causes apoptotic cell death of
BCAECs through the mitochondria-mediated pathway. This conclusion is supported by
the following evidence: 1) cocaine-induced apoptosis was inhibited by cyclosporin A, 2)
cocaine caused translocation of cytochrome c from the mitochondria to the cytosol,
which was blocked by cyclosporin A, 3) cocaine-induced activation of caspase-9
preceded caspase-3 whereas caspase-8 was not activated.

Whereas the precise

mechanisms underlying cocaine-induced cytochrome c release in BCAECs are not
entirely clear at present, the down-regulation of the Bcl-2 protein is likely to play an
important role.
Cocaine-induced apoptotic cell death of BCAECs was clearly demonstrated by
plasma membrane phosphatidylserine translocation and nuclear morphological changes in
the present study. Similar findings were obtained in human coronary artery endothelial
cells (He et ah, 2000). In both human and bovine coronary artery endothelial cells,
cocaine induced apoptosis starting at the concentration of 10 pM. The EC50 of cocaine is
50 pM in these cells. Because serum levels of cocaine in active drug abusers are often
>100 pM and the repeated uses of cocaine produce dose-related accumulation in serum
cocaine concentration (Benowitz, 1993; Jufer et ah, 1998; Nassogne et ah, 1997), the
pathophysiological relevance of the present finding is fully warranted. In agreement with
the previous findings in the human cells (He et ah, 2000), the present study demonstrated
that cyclosporin A produced a dose-dependent inhibition of cocaine-induced apoptosis,
suggesting that release of cytochrome c from the mitochondria plays a key role in
cocaine-induced apoptosis in these cells. The finding of cocaine-induced cytochrome c
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translocation from the mitochondria to the cytosol provides a direct link between the
mitochondria and cocaine-induced apoptosis in BCAECs. In accordance with the finding
that it inhibited cocaine-induced apoptosis, cyclosporin A blocked cocaine-induced
cytochrome c translocation in BCAECs.

Similar findings were obtained in human

endothelial cells in which cyclosporin A was shown to block oxidized LDL-induced
apoptosis and cytochrome c release (Walter et al., 1998).

The notion that cocaine

activates the mitochondrial apoptotic pathway in BCAECs has been further supported by
the time course studies of cocaine-mediated activation of caspase-9, caspase-8, and
caspase-3 in the present study. The finding that cocaine-mediated activation of caspase-9
preceded that of caspase-3 clearly demonstrated that caspase-9 functions as an initiator
caspase in cocaine-induced caspase cascade. The activation of caspase-9 by cytochrome
c and apoptosis activating factor-1 (Apaf-1) has been well documented (Green and Reed,
1998; Zou et al., 1999). Whereas caspase-9 can also be activated by caspase-8 through a
death receptor-mediated pathway (Ashkenazi and Dixit, 1998), the lack of effect of
cocaine on caspase-8 precludes the potential activation of caspase-9 by caspase-8 and
suggests that death receptor/caspase-8 pathway may not be involved in cocaine-induced
apoptosis of BCAECs.

In agreement with the present finding, our previous study

demonstrated that cocaine-induced apoptosis of coronary artery endothelial cells was
inhibited by the inhibitors of caspase-9 and caspase-3 (He et al., 2000). Taken together,
these findings demonstrate that cocaine-induced apoptosis in BCAECs is mediated by the
mitochondrial pathway, and the release of cytochrome c and its subsequent activation of
caspase-9 and caspase-3 play a key role in cocaine-induced apoptosis.
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Although the mechanisms underlying cocaine-induced cytochrome c release in
BCAECs are not entirely clear at present, the finding that cyclosporin A inhibited both
cocaine-induced cytochrome c release and apoptosis suggests that loss of mitochondrial
membrane potential (A^m) may contribute to cocaine-induced release of cytochrome c.
In many cells, one of the early characteristics of apoptosis is the loss of

resulted

from dissipation of the H+ gradient after opening of the permeability transition pore in the
inner mitochondrial membrane (Green and Reed, 1998). Cyclosporin A prevents
cytochrome c release by stabilizing the mitochondrial transmembrane potential and
inhibits apoptosis (Green and Reed, 1998; Jurgensmeier et ah, 1998; Marzo et ah, 1998;
Walter et ah, 1998). It has been reported that cocaine inhibits the activity of the terminal
electron transport system of the mitochondria in fetal rat heart and decreases the heart
rate (Fantel et ah, 1990). More recent studies showed that cocaine caused a dose- and
time-dependent decrease in mitochondrial membrane potential in primary cultures of rat
cardiomyocyte, and the decline of the membrane potential occurred prior to the
manifestation of cytotoxicity shown with the exposure of cocaine (Yuan and Acosta,
1996).
Whereas changes intrinsic to the mitochondria are likely to ultimately mediate
cytochrome c release, the present study cannot distinguish whether loss of A^ causes
the initial release of cytochrome c or merely amplifies the release initiated by other
mechanisms. Additionally, it has been demonstrated that the opening of an inner
membrane permeability transition pore is not the only mechanism mediating cytochrome
c release (Green and Reed, 1998). Members of the Bcl-2 family of proteins have been
demonstrated to be associated with the mitochondrial membrane and regulate its integrity
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(Adams and Cory, 1998). Among over 15 different proteins in the Bcl-2 family, the antiapoptotic Bcl-2 protein has been found to be associated with mitochondrial membrane
and to prevent both the loss of mitochondrial membrane potential and the efflux of
cytochrome c. In contrast, Bax protein has a pro-apoptotic effect and causes release of
cytochrome c. In the present study, both Bcl-2 and Bax proteins were expressed in
BCAECs, with higher levels of the Bcl-2 protein. This is in contrast with the previous
findings in cultured cardiac myocytes isolated from near-term fetal rats, which showed
much lower content of Bcl-2 than that of Bax (Wang et al., 1998). Nevertheless, a recent
study demonstrated a developmental regulation of anti-apoptotic and pro-apoptotic
proteins in rat heart such that Bcl-2 and Bcl-xL levels were sustained during
development, but Bax and Bad levels were down-regulated (Cook et al., 1999). The
higher ratio of Bcl-2/Bax in adult cells may be associated with the withdrawal of adult
cells from the cell cycle in the perinatal period.
The present finding that Bcl-2 proteins decreased in response to cocaine suggests
that the Bcl-2 protein may play a key role in cocaine-induced apoptosis of BCAECs.
Whereas the mechanisms underlying cocaine-mediated reduction of Bcl-2 are not clear at
present, we speculate that nitric oxide may be involved. We have found that cocaine
inhibits nitric oxide synthesis in BCAECs (data not shown).

Nitric oxide as a

bifunctional regulator of apoptosis has been proposed recently (Kim et al., 1999).
Depending on cell types and concentrations, nitric oxide can be a cytotoxic effector in
some cells, but a protector against apoptosis in other cells including endothelial cells
(Dimmeler et al., 1997; Kim et al., 1999). It has been demonstrated that nitric oxide
maintains caspase-3 zymogen in an inactive form by S-nitrosylation of the catalytic-site
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cysteine (Mannick et al., 1999), inhibits Bcl-2 cleavage by caspase-3, and inhibits
cytochrome c release (Kim et al., 1998; Kim et al., 1999). In the present study, we found
that cocaine-induced down-regulation of Bcl-2 protein was partially blocked by caspase-3
inhibitor Ac-DEVD-CHO. However, because cyclosporin A, which blocked cocaineinduced cytochrome c release, had no effect on cocaine-induced decrease in the Bcl-2
protein, it is likely that cocaine-induced decrease in Bcl-2 is an upstream signal of
cytochrome c release in BCAECs. Collectively, our data suggest that cocaine-mediated
and mitochondria-independent activation of caspase-3 and cleavage of Bcl-2, probably
through an inhibition of nitric oxide, may serve as a trigger that is amplified by the
mitochondria/cytochrome c pathway in BCAECs. Additional experiments are needed to
determine whether a reduction of nitric oxide increases caspase-3 activity and decreases
Bcl-2 in BCAECs and whether a nitric oxide donor rescues cocaine-mediated apoptosis.
Unlike Bcl-2, cocaine did not change Bax protein levels in the present study. This
is in contrast to our previous findings in fetal rat heart and brain in which cocaine
increases Bax expression (Xiao et al., 2000a; Xiao et al., 2000b). Similar findings were
obtained in rat heart after coronary occlusion (Liu et al., 1998) and cardiac myocytes
exposed to cytokines (Ing et al., 1999). However, the present finding of no change in
Bax protein levels does not necessarily preclude the potential role played by Bax in
cocaine-induced apoptosis in BCAECs. In contrast to Bcl-2, which is localized to the
outer mitochondrial membrane, Bax is predominantly present in the cytosol. Indeed, it
has been well documented that one of the crucial steps before Bax can exert its proapoptotic activity is translocation from the cytosol to the mitochondria and induction of
cytochrome c release, and Bcl-2 exerts its anti-apoptotic activity partly by inhibiting the
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translocation of Bax to the mitochondria (Murphy et al., 2000a; Murphy et ah, 2000b;
Nomura et ah, 1999).

By down-regulating Bcl-2 levels in BCAECs, cocaine may

promote the translocation of Bax from the cytosol to the mitochondrial membrane leading
to the release of cytochrome c.
In summary, we have shown that cocaine induces a dose-dependent increase in
apoptotic cell death in cultured bovine coronary artery endothelial cells. Cocaineinduced apoptosis in BCAECs is associated with the release of cytochrome c from the
mitochondria into the cytosol, and the subsequent activation of caspase-9 and caspase-3.
The decrease in the Bcl-2 protein in response to cocaine may play a key role in the loss of
mitochondrial membrane potential and the release of cytochrome c. Whereas it is
speculated that cocaine-induced decrease in Bcl-2 may cause the translocation of Bax
from the cytosol to the mitochondria, the direct evidence remains elusive. Increased
apoptosis of coronary artery endothelial cells results in endothelial dysfunction, and is
likely to play a key role in cocaine-induced coronary artery vasoconstriction leading to
myocardial ischemia and infarction. In addition, because phosphatidylserine is a potent
surface procoagulant and it has been demonstrated that human endothelial cells with
phosphatidylserine extemalization during apoptosis were markedly procoagulant
(Casciola-Rosen et al., 1996), cocaine-induced phosphatidylserine extemalization in
BCAECs may cause pathological intravascular coagulation events and impair coronary
circulation, which may also contribute in part to cocaine-induced myocardial ischemia
and infarction.
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Figure 1. Cocaine-induced phosphatidylserine translocation in bovine coronary
artery endothelial cells (BCAECs). BCAECs were double-stained with 6-CFDA and
Annexin V-Cy3 and photographed with fluorescence microscopy in the absence (panel
A) and presence (panel B & C) of 100 pM cocaine for 48 h. Panel A shows live cells
stained with 6-CFDA only (green). Panel B shows cocaine-induced apoptotic cells
stained with both Annexin V-Cy3 (red) and 6-CFDA (green), indicating the binding of
Annexin V-Cy3 to phosphatidylserine at the cell surface. The apparent yellow
fluorescence results from the summing of red and green fluorescence. Panel C shows
necrotic cells stained only with Annexin V-Cy3 (red). Similar results were obtained from
two additional separated experiments. Bar, 20 pm.

90

%

#
i
9

1 mm
'
I
0

%

>i|

i..C

<

CQ

O

Figure 2. Cocaine-induced nuclear morphological changes in bovine coronary
artery endothelial cells (BCAECs). Cells were stained with DNA binding florescence
dye Hoechst 33258 and nuclear morphology was examined by fluorescence microscopy
in the absence (panel A) and presence (panel B) of 100 pM cocaine for 48 h. The arrows
show condensed, coalesced and segmented apoptotic nuclei. Quantitative data are shown
in Fig. 3. Bar, 50 pm.
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Figure 3. Cocaine-induced dose-dependent increase in apoptosis and decrease in cell
viability in bovine coronary artery endothelial cells (BCAECs). BCAECs were
incubated with indicated concentrations of cocaine for 48 h. Cell viability was
determined by trypan blue exclusion assay, and the number of apoptotic cells was
determined by Hoechst 33258 fluorescence staining as described in the Methods. Data
are means ± SEM for three experiments.
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Figure 4. Inhibition of cocaine-induced apoptosis by cyclosporin A in bovine
coronary artery endothelial cells (BCAECs). BCAECs were incubated with cocaine
(100 pM for 48 h) in the absence or presence of increasing concentrations of cyclosporin
A. The number of apoptotic cells was determined by Hoechst 33258 staining as
described in the Methods. Data are means ± SME for four experiments.

96

120-,
<D

w
c 100-

o
Q.
(0 80o
®
c
ro
o
o
O
^

6040200
-8

-7

-6

Log [Cyclosporin A] (M)

97

-5

Figure 5. Effect of cocaine on cytochrome c translocation in bovine coronary artery
endothelial cells (BCAECs). BCAECs were incubated with cocaine (100 |uM for 48 h)
in the absence and presence of cyclosporin A (CSA, 1 pM). Cytosolic and mitochondrial
fractions were separated as described in the Methods. Proteins from the two fractions
were separated on 15% SDS-polyacrylamide gel, and cytochrome c was detected by
Western blotting using monoclonal cytochrome c antibody. The upper panel shows the
representative Western immunoblots. The lower panel shows the quantitative results.
Data are expressed as percent of the control levels for four independent experiments. C:
Control; COC: Cocaine. */? < 0.05 vs. the control.

98

coc
+

c

COC

CSA

CSA

Mitochondria
fraction cyto-c

15Kd

Cytosol
fraction cyto-c

15Kd

Mitochondria fraction

Cytosol fraction
*

2-,

O

c
o 1_

o

I

p

o

*

0
C COC COC CSA
+
CSA

C

99

COC COC CSA
+
CSA

Fig. 6. Time courses of cocaine-mediated activation of caspase-3, caspase-8, and
caspase-9 in bovine coronary artery endothelial cells (BCAECs). BCAECs were
treated with 100 jaM cocaine for the time periods indicated. Caspase activities were
determined as described in the Methods. At each time point, values are expressed as the
percent of caspase activities of cocaine-treated samples versus the corresponding
controls. Data are means ± SEM for four experiments. * /? < 0.05 vs. the control.
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Fig. 7. Effect of cocaine on Bcl-2 protein expression in bovine coronary artery
endothelial cells (BCAECs). BCAECs were incubated with cocaine (30 and 100 pM for
48 h) in the absence and presence of cyclosporin A (CSA, 1 pM). Proteins were
separated on 12% SDS-polyacrylamide gel, and Bcl-2 was detected by Western blotting
using a monoclonal antibody. Actin was used as a loading control. The upper panel
shows the representative Western immunoblots. The lower panel shows the quantitative
results. Data are expressed as percent of the control levels for five independent
experiments. C: Control; COC: Cocaine. */? < 0.05 vs. the control.
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Fig. 8. Effect of Ac-DEVD-CHO on cocaine-induced downreguiation of Bcl-2
protein in bovine coronary artery endothelial cells (BCAECs). BCAECs were
incubated with cocaine (100 pM for 48 h) in the absence and presence of caspase-3
inhibitor Ac-DEVD-CHO (DEVD, 100 pM). Proteins were separated on 12% SDSpolyacrylamide gel, and Bcl-2 was detected by Western blotting using a monoclonal
antibody. Data are expressed as percent of the control levels for four independent
experiments. C: Control; COC: Cocaine. */? < 0.05 vs. the control; +p< 0.05 vs.
cocaine alone.
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Fig. 9. Effect of cocaine on Bax protein expression in bovine coronary artery
endothelial cells (BCAECs). BCAECs were incubated with cocaine (30 and 100 \xM for
48 h). Proteins were separated on 12% SDS-polyacrylamide gel, and Bax was detected
by Western blotting using a monoclonal antibody. Actin was used as a loading control.
The upper panel shows the representative Western immunoblots. The lower panel shows
the quantitative results. Data are expressed as percent of the control levels for three
independent experiments. C: Control; COC: Cocaine.
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CHAPTER 4
COCAINE-MEDIATED APOPTOSIS IN BOVINE CORONARY ARTERY
ENDOTHELIAL CELLS: ROLE OF NITRIC OXIDE

Jiale He, Yuihui Xiao, Lubo Zhang

This chapter is in press in the Journal of Pharmacology & Experimental Therapeutics.
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Abstract
The present study examined the role of nitric oxide in cocaine-induced apoptosis
in bovine coronary artery endothelial cells (BCAECs). Cocaine produced a timedependent decrease in cell viability and an increase in apoptosis in BCAECs, which were
blocked by the nitric oxide donors, DETA-NONOate (DETA-NO) and S-nitroso-nacetyl-penicillamine. In accordance, cocaine decreased nitric oxide production in
BCAECs at each time point of the study. Cocaine significantly increased caspase-3
activity that was blocked by the inhibitors of cytochrome c release (cyclosporin A),
caspase-3 (Ac-DEVD-CHO) and caspase-9 (Z-LEHD-FMK), respectively. In addition,
cocaine activated caspase-9, which was blocked by cyclosporin A and Z-LEHD-FMK.
Ac-DEVD-CHO only partially blocked cocaine-induced caspase-9 activity. DETA-NO
(20 pM) blocked cocaine-mediated activation of both caspase-9 and caspase-3. Cocaine
decreased Bcl-2 protein levels, which was partially blocked by Ac-DEVD-CHO and ZLEHD-FMK, but not by DETA-NO. Furthermore, cocaine induced a translocation of Bax
from the cytosol to the mitochondria in BCAECs, and increased Bax levels in
mitochondria by 2.2-fold. In accordance, cytosolic Bax levels decreased about 42%.
Neither Ac-DEVD-CHO nor DETA-NO affected cocaine-induced translocation of Bax.
We conclude that cocaine-induced Bcl-2 protein downregulation and Bax translocation to
the mitochondria are upstream signals of caspase-9 activation that precede caspase-3.
Cocaine-induced attenuation of nitric oxide plays a key role in the activation of the
caspase cascade in BCAECs.
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Introduction
Endothelium not only plays an important role in regulating vascular tone by
releasing nitric oxide (NO) but also participates in many other cellular processes such as
hemostasis, cellular proliferation, inflammation, and immunity. The apoptotic cell death
of endothelium has been implicated in the processes of endothelial denudation,
angiogenesis, thrombosis, and atherosclerosis (Lopez-Farre et ah, 1998). We have
recently demonstrated that cocaine induces apoptosis in coronary artery endothelial cells
and fetal cardiomyocytes (He et ah, 2000a, Xiao et ah, 2000). Cocaine-induced apoptosis
in coronary endothelium was associated with the release of cytochrome c from the
mitochondria into the cytosol, and the subsequent activation of caspase-9 and caspase-3
(He et ah, 2000b). It is likely that Bcl-2 family proteins play an important role in cocainemediated cytochrome c release. Cocaine decreased Bcl-2 protein levels but had no effect
on Bax levels in coronary endothelial cells (He et ah, 2000b).
Recent studies suggested that cocaine impaired endothelial NO synthesis (Mo et
ah, 1998; Mazzio et ah, 2000). The effects of NO on apoptosis are highly tissue/cell
specific (Kim et ah, 1999). Studies have suggested that NO donors or stimulation of NO
synthase induces apoptosis in a variety of cell types (Fehsel et ah, 1995; Koglin et ah,
1999; Matsuzaki et ah, 1999). However, in endothelial cells, NO seems to have an antiapoptotic effect (Ceneviva et ah, 1998; Femandez-Tome et ah, 1999; Tzeng et ah, 1997).
It has been suggested that basal production of NO from constitutive endothelial isoform
NO synthase is able to protect endothelial cells from apoptosis (Li and Billiar, 2000).
NO suppressed caspase activity by its direct interaction with caspases leading to Snitrosylation of the cysteine residue which locates at catalytic sites of all caspases (Li et
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al., 1997; Mannick et al., 1999; Rossig et al., 1999). In addition, NO inhibited Bcl-2
protein cleavage and cytochrome c release (Kim et al, 1998). It is likely that multiple
mechanisms may be involved in NO-mediated protection of apoptosis (for review, see
Kim et al., 1999; Li and Billiar, 2000). Nevertheless, the role of NO in cocaine-induced
apoptosis in coronary artery endothelial cells is unknown.
The present study was conducted to test the hypothesis that cocaine inhibits NO
production, which plays a key role in cocaine-induced apoptosis in bovine coronary
artery endothelial cells. The specific objectives of this study were to determine in bovine
coronary artery endothelial cells: 1) whether cocaine decreased NO production, which
preceded cocaine-mediated apoptosis, 2) whether the NO synthase inhibitor L-NAME
mimicked cocaine’s effects and induced apoptosis, 3) whether the NO donor DETANONOate (DETA-NO) inhibited cocaine-induced apoptosis, 4) whether DETA-NO
inhibited cocaine-mediated activation of caspase-9 and caspase-3, and 5) whether DETANO inhibited cocaine-induced decrease in Bcl-2 protein levels and/or Bax translocation
from the cytosol to the mitochondria.
Materials and Methods
Materials. Cocaine, cyclosporin A, N-nitro-L-arginine methyl ester (L-NAME),
S-Nitroso-N-Acetyl-Penicillamine (SNAP) and anti-actin antibody were purchased from
Sigma (St. Louis, MO). DETA-NONOate was from A.G. Scientific (San Diego, CA). ZLEHD-FMK was from Kamiya Biomedical (Seattle, WA). Fetal bovine serum was
purchased from Hyclone Laboratories (Logan, UT). Protein assay reagents were from
Bio-Rad (Hercules, CA). Ac-DEVD-CHO and anti-Bax antibody were from Pharmingen
(San Diego, CA). Anti-Bcl-2 antibody was from Santa Cruz Biotechnology (Santa Cruz,
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CA). Horseradish peroxidase (HRP)-conjugated anti-mouse IgG was from Amersham
Life Science (Clearbrook, IL). MTT cell viability assay kit, and aspase-3 and caspase-9
colorimetric assay kits were from R&D Systems (Minneapolis, MN).
Cell Culture. Bovine coronary artery endothelial cells (BCAECs) were obtained
from Cell Applications, Inc. (San Diego, CA). Cells were grown in complete medium of
Dulbecco’s Modified Eagle’s Medium (DMEM, Mediatech Cellgro Inc., VA) with
glucose (4.5 g/1), 15% fetal bovine serum, 100 U/ml penicillin, 100 pg/ml streptomycin.
Cells were incubated at 37 °C in a humidified incubator with 5% CO2,95% air, and used
for the experiments at the fifth and sixth passages at 80% confluence. Twenty four hours
before the treatment, the medium was replaced with the serum-free medium.
Cell Viability. MTT assay kit (R&D Systems Inc.) was used to determine cell
viability. The principle of the assay was based on the reduction of MTT by metabolically
active cells to insoluble purple formazan dye crystals. The experiments were performed
in 96-well plates. At the end of each experiment, the cells in each well were incubated
with 10 pi MTT reagent for 2 hours at 37 °C. The formazan crystals were then
solubilized with 100 pi detergent solution provided in the kit in the dark for at least 2
hours. The absorbance was measured at 570 nm, with 690 nm as reference using a
microplate reader. The data were calculated using a standard curve and expressed as a
percentage.
Quantitative Analysis of Apoptotic Cells. Fluorescent DNA-binding dye
Hoechst 33258 was used to define nuclear chromatin morphology as a quantitative index
of apoptosis as described previously (He et ah, 2000a, b). Briefly, after each experiment,
cells growing on cover slides were fixed by methanol/acetic acid (v/v 3:1) at 4 °C for 5
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min and stained with Hoechst 33258 for 10 min at room temperature in the dark. After
mounting, the morphological changes of the nuclei of apoptotic cells were visualized by
fluorescent microscopy. The number of apoptotic cells and total cells were counted in 6
randomly selected high power fields under a fluorescent microscope (approximately 400
cells /cover slide). The percentage of apoptotic cells was calculated as the number of
apoptotic cells/number of total cells x 100%.
Measurement of NO*. NO was measured by chemiluminescence method as
described previously (Yang et al., 2000). Because of the instability of NO in
physiological solution, most of NO is rapidly converted to nitrite (NO2") and further to
nitrate (NO3'). Nitrite and nitrate are relatively stable in the solution, and are readily
reduced back to NO in vanadium (III)/HC1 solution. The samples (100 pi) taken from the
medium were injected into the gas purge vessel containing 5 ml vanadium (III)/HC1 and
allowed to react for 1 min and reduce nitrate/nitrite in the sample back to NO. To
achieve high reducing efficiency, the reduction was performed at 90 °C. NO in the
sample was then “stripped” into the head space of the gas purge vessel by bubbling it
with helium (12 ml/min) for 60 sec. NO in the head space was drawn into a NO
Analyzer (Model 270B, Sievers Instruments, Inc., Boulder, CO) and mixed with ozone
(O3) in front of a cooled Hamamatsu, red-sensitive photomultiplier tube. Signals from
the detector were analyzed by an on-line computer as area under the peak. The
measurement reflected the combined concentrations of nitrate, nitrite, and nitric oxide
(NOx) of each sample, which was calculated from a standard curve of 10 to 1000
picomoles nitrate run in each assay.
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Western Blot Analysis. Bcl-2 and Bax proteins were determined with Western
analysis as described previously (He et al., 2000b). Briefly, bovine coronary artery
endothelial cells were harvested after treatments, and homogenized in ice-cold lysis
buffer (20 mM HEPES, pH 7.5, 10 mM KC1, 1.5 mM MgCl2, 1 mM EDTA, 1 mM
EGTA, 1 mM DTT, 1 mM PMSF, 2 pg/ml aprotinin, 10 pg/ml leupeptin) for 30 min.
After centrifugation, proteins in the supernatant were quantified by a standard
colorimetric assay (Bio-Rad), and were used to determine Bcl-2 protein levels. To
determine Bax translocation from the cytosol to the mitochondria, the cytosolic and
mitochondrial fractions were separated and the protein content of each fraction was
determined as described previously (He et al., 2000b). The proteins were separated by
12% SDS-PAGE, transferred to nitrocellulose membranes, and incubated with primary
antibodies against Bax (1:250) and Bcl-2 (1:2000), respectively in TBS-T buffer
containing 4% nonfat milk. After washing, the membranes were incubated with HRPconjugated anti-mouse IgG (1:2000), and visualized using an enhanced
chemiluminescence detection system (Amersham). Results were quantified by
densitometric analysis using a Bio-Rad densitometer (model 670). The data were
normalized by actin and presented as the percentage of the control protein levels within
each group.
Caspase Activity Assay. Activities of caspase-3 and caspase-9 were determined
using the corresponding caspase activity detection kits (R&D Systems) as described
previously (He et al., 2000b). Briefly, 100 pg total cell protein was added to 50 pi
reaction buffer and 5 pi substrates of DEVD-pNA and LEHD-pNA, respectively.
Samples were incubated at 37 °C for 3 h and the enzyme-catalyzed release ofp'NA was
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quantified at 405 nm using a microtiter plate reader. The values of treated samples were
normalized to corresponding untreated controls allowing determination of the fold
increase in caspase activity.
Statistical Analysis. Data were presented as the mean ± S.E.M. Statistical
analysis were performed by one-way ANOVA followed by the Newman-Keuls post hoc
test. Full factorial two-way ANOVA with Bonferroni correction was used to analyze
data in figures 2 and 4. Differences were considered significant at p < 0.05.
Results
Effects of cocaine on NO production. The effect of cocaine on basal NOx
release in bovine coronary artery endothelial cells (BCAECs) is shown in Fig. 1. The
cells were treated with control medium or medium with 100 pM cocaine for up to 72 h.
NO (measured as NOx) in the medium was assayed by chemiluminescence method. Over
the 72-h period of the treatment, basal NOx continued to accumulate in the medium. As
shown in Fig. 1, cocaine significantly decreased NOx release from BCAECs at each time
point of the study.
Effects of NO donors on cocaine-induced apoptosis. We have previously
demonstrated in BCAECs that cocaine induces apoptosis, which is reflected by decreased
cell viability (He et ah, 2000). To study the effects of exogenous NO on cocaine-induced
apoptosis, we first used 20 pM DETA-NO as the NO donor. This compound
spontaneously decomposes to release two NO molecules with a half-life of ~50 hours in
cell culture medium, and 20 pM DETA-NO gives 80-100 nM steady-state concentration
of NO for at least 48 hours, which resembles the physiological level of NO (1-200 nM) in
the tissue (Beckman, 1999; Brown, 1999). As shown in Fig. 2, there was a spontaneous
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reduction in cell viability of BCAECs that occurred over the 72-h culture period in the
serum-free medium. Consistent with our previous reports (He et al., 2000a; He et al..
2000b), cocaine significantly exacerbated cell death of BCAECs in a time-dependent
manner. As compared with the control, cells treated with cocaine started to show a
significant decline in cell viability at 12 h (12% decline) and continued up to 72 h (35%
decline) {p < 0.001, cocaine vs. control). Although 20 pM DETA-NO alone had no effect
on cell viability as compared with the control {p - 0.134, DETA-NO vs. control), it
reversed the cocaine-induced decrease in cell viability (Fig. 2) (/? = 0.074, DETANO+cocaine vs. control).
To confirm apoptotic cell death, nuclear morphology was examined by the DNAbinding dye Hoechst 33258. As demonstrated previously (He et al., 2000b), apoptotic
cells showed condensed, coalesced, and segmented nuclei (Fig. 3A). Cocaine
significantly increased apoptosis after 24-hour treatment, which was blocked by DETANO (Fig. 3B). To examine the specific effect of NO, NO was depleted from DETA-NO
by decomposing it for six half-lives. In contrast to the parent compound, decomposed
DETA-NO with depleted NO showed no effect on the cocaine-induced apoptosis (Fig.
3B), suggesting that the antiapoptotic effect of DETA-NO was due to the release of NO.
This was further confirmed by another NO donor SNAP. As shown in Fig. 3B, SNAP
dose-dependently inhibited the cocaine-induced apoptosis.
To test whether the inhibition of NO production would mimic cocaine’s effects,
we examined the effects of endothelial NO synthase inhibitor L-NAME on cell viability
of BCAECs. As shown in Fig. 4, incubation of BCAECs with 100 pM L-NAME resulted
in a time-dependent decrease in cell viability as compared with the control (p < 0.001, L-
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NAME vs. control). Nevertheless, L-NAME induced decreases in cell viability to a less
extent, as compared with cocaine (p < 0.001, L-NAME vs. cocaine). Apoptotic cell death
induced by L-NAME was confirmed by the examination of nuclear morphology using
Hoechst 33258. L-NAME (100 pM) treatment for 24 hours significantly increased
apoptotic cells from 6.08 ± 0.53% to 10.64 ± 0.53% (p < 0.05).
Effects of DETA-NO on cocaine-induced caspase activation. Although the
role of NO on cell death is still controversial, many studies have suggested that NO
directly inhibits caspase family members by S-nitrosylation ( Li et al., 1997; Haendeler et
al., 1997). We have previously demonstrated that cocaine activates both caspase-9 and
caspase-3, but not caspase-8 in BCAECs (He et al., 2000b). To test whether the
inhibitory effects of DETA-NO on cocaine-induced cell death were mediated by
inhibiting caspase activation induced by cocaine, we examined the effects of DETA-NO
on cocaine-induced activation of caspase-9 and caspase-3 in BCAECs. As shown in Fig.
5, consistent with our previous studies (He et al, 2000b), cocaine treatment for 24 h
increased caspase-3 activity 1.9-fold. Although cyclosporin A (cytochrome c release
inhibitor), Ac-DEVD-CHO (caspase-3 inhibitor), and Z-LEHD-FMK (caspase-9
inhibitor) did not change the basal caspase-3 activity, they all blocked cocaine-induced
increase in caspase-3 activity (Fig. 5). Similarly, cocaine increased caspase-9 activity
1.8-fold, which was blocked by cyclosporin A and Z-LEHD-FMK (Fig. 6). However, the
caspase-3 inhibitor Ac-DEVD-CHO only partially blocked cocaine-induced increase in
caspase-9 activity (Fig. 6). None of the inhibitors had effects on the basal caspase-9
activity. As shown in Fig. 7, DETA-NO (20 pM) itself had no effect on activities of
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either caspase-3 or caspase-9, but completely blocked cocaine-induced activation of both
caspase-3 and caspase-9 in BCAECs.
Effects of DETA-NO on cocaine-induced cleavage of Bcl-2. Our previous
study has demonstrated that cocaine induces a decrease in Bcl-2 protein levels, which is
partially mediated by activated caspase-3, suggesting a positive feedback amplification of
the proapoptotic signaling. In an attempt to understand whether NO was involved in
cocaine-mediated cleavage of Bcl-2, we determined the effects of DETA-NO on Bcl-2
protein expression in the presence of cocaine by Western blot analysis. As shown in Fig.
8, the representative Western immunoblot showed that the monoclonal antibody for the
Bcl-2 protein detected a single band at expected size of 29 kDa (Fig. 8, upper panel).
Consistent with our previous findings (He et al., 2000b), cocaine decreased Bcl-2 protein
levels in BCAECs. DETA-NO (20 pM) had no effect on cocaine-induced decrease in the
Bcl-2 protein. In contrast, both the caspase-3 inhibitor Ac-DEVD-CHO and the caspase-9
inhibitor Z-LEHD-FMK partially blocked cocaine-induced cleavage of Bcl-2.
Effects of DETA-NO on cocaine-induced Bax translocation from the cytosol
to the mitochondria. We have previously demonstrated that cocaine has no effects on
Bax protein levels in BCAECs (He et al., 2000b). Other studies showed that Bax
translocated from the cytosol to the mitochondria in response to certain apoptotic signals
(Putcha et al., 1999; Nomura et al, 1999). To test whether Bax translocation occurred in
BCAECs exposed to cocaine, we determined subcellular localization of Bax in the
cytosolic and mitochondrial fractions by Western blot analysis. The representative
Western immunoblot showed that the monoclonal antibody for Bax detected a single
band at expected size of 21 kDa (Fig. 9, upper panel). As shown in Fig. 9, in control cells
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Bax was almost exclusively located in the cytosolic fraction. After cocaine treatment,
there was an 1.2-fold increase in Bax levels in the mitochondrial fraction and an
accordant 42% decrease in Bax levels in the cytosolic fraction. As also shown in Fig. 9,
neither the caspase-3 inhibitor Ac-DEVD-CHO nor DETA-NO had effects on cocaineinduced Bax translocation.
Discussion
The present study demonstrates for the first time that cocaine decreases NO
release from endothelial cells, and suggests a role for the decreased NO in cocainemediated apoptotic cell death in bovine coronary artery endothelial cells (BCAECs).
This is supported by the following evidence: 1) the cocaine-mediated decrease in NO
production preceded cocaine-induced decrease in cell viability, 2) the NO synthase
inhibitor L-NAME mimicked cocaine’s effects and decreased cell viability, 3) the NO
donor DETA-NO inhibited cocaine-induced cell death. Although the precise
mechanisms underlying the protective effects of NO on cocaine-mediated apoptosis are
not entirely clear at present, the inhibition of caspase activation is likely to play a key
role.
The role of NO in apoptosis is controversial and complex depending on the cell
type, cell sensitivity to NO, and NO levels (Kim et al., 1999). One explanation for the
paradoxical findings in different studies is likely to be the source of NO donors used in
each study. Nitrosothiols have been widely used as NO donors. However, because
nitrosothiols have their own chemical reactivities distinct from NO, and are far more
reactive with biological thiols than NO, their actions cannot be simply equated with NO
(Beckman, 1999). In the present study, we used DETA-NO as a NO donor, and 20 pM
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DETA-NO would maintain a steady-state concentration of 100 nM of NO in cell culture
medium for at least 48 hours, which resembled the physiological levels of NO (1-200 nM)
in the tissue (Beckman, 1999; Brown, 1999). Studies have suggested that at low
concentrations NO mainly functions as an antiapoptotic molecule, although excessive NO
may induce cytotoxicity (Li and Billiar, 2000). The present finding that DETA-NO
inhibited cocaine-induced apoptosis in BCAECs is in agreement with previous results
that exogenous NO protected endothelial cells from apoptotic stimuli (Ceneviva et al.,
1998; DeMeester et al., 1998; Ho et al., 1999; Tzeng et al., 1997). The finding that
decomposed DETA-NO with depleted NO showed no effect on the cocaine-induced
apoptosis confirms that the antiapoptotic effect of DETA-NO is due to the release of NO.
This was further supported by another NO donor SNAP, which dose-dependently
inhibited the cocaine-induced apoptosis. Furthermore, the finding that L-NAME
decreased cell viability and increased apoptosis in BCAECs suggests that endogenous
NO is likely to play an important role in protecting BCAECs from apoptosis. In a
previous study, DeMeester et al. (1998) demonstrated that the NO synthase inhibitor, N“methyl-L-arginine did not affect lipopolysaccharide-induced apoptosis in pig aortic
endothelial cells, and concluded that endogenous NO did not inhibit endothelial cell
apoptosis. However, the direct effect of the NO synthase inhibitor on endothelial cell
apoptosis was not determined in their study (DeMeester et al., 1998). In the present
study, we found that cocaine inhibited NO release, and the decreased NO preceded
cocaine-induced apoptosis in BCAECs. Collectively, our data suggest that a reduction in
endogenous NO is likely to play an important role in cocaine-mediated cell death in
BCAECs. Nonetheless, the finding that L-NAME decreased cell viability to a less extent
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compared with cocaine suggests that decreased NO may not be the only mechanism by
which cocaine mediated apoptosis in BCAECs.
It is likely that multiple mechanisms are involved in NO-mediated antiapoptotic
effects. Previous studies demonstrated that NO reversibly inhibited seven members of the
caspase family via S-nitrosylation in hepatocytes (Li et al., 1997). We have previously
shown the participation of caspases-3 and caspase-9 but not caspase-8 in cocaine-induced
apoptosis in coronary artery endothelial cells (He et al., 2000a; He et al., 2000b). In the
present study, we demonstrated that cocaine-induced activation of caspase-3 and caspase9 was blocked by cyclosporin A, which inhibits cytochrome c release from mitochondria
by stabilizing mitochondrial transmembrane potential (Green and Reed, 1998). We have
previously demonstrated that cocaine induces cytochrome c release from mitochondria,
and cyclosporin A inhibits cocaine-induced cytochrome c release and apoptosis in
coronary artery endothelial cells (He et al., 2000a; He et al., 2000b). Collectively, these
results suggest that cocaine-mediated cytochrome c release precedes the activation of
caspase-3 and caspase-9. In addition, the present finding that cocaine-induced activation
of caspase-3 was completely blocked by Z-LEHD-FMK, which blocked cocaine-induced
caspase-9 activation, suggests that activation of caspase-9 precedes caspase-3 in cocainestimulated caspase cascade in BCAECs. This is further supported by the finding that the
caspase-3 inhibitor Ac-DEVD-CHO only partially blocked cocaine-induced caspase-9
activation. The fact that Ac-DEVD-CHO partially blocked caspase-9 activation suggests
a positive feedback of caspase-3 on the upstream caspase(s).
The present study clearly demonstrated that DETA-NO blocked cocaine-induced
activation of both caspase-3 and caspase-9 in BCAECs. It has been demonstrated that NO
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maintains caspase-3 zymogen in an inactive form by S-nitrosylation of the catalytic-site
cysteine (Mannick et al., 1999; Rossig et al., 1999). To our knowledge, the inhibition of
caspase-9 activity by NO has not been previously studied. It is not clear at present
whether NO inhibits caspase-9 activity directly by S-nitrosylation or indirectly by
inhibiting the loss of mitochondrial inner transmembrane potential and cytochrome c
release. In a recent study, Li et al., (1999) demonstrated that NO blocked
TNFa/actinomycin D-induced reduction in mitochondrial transmembrane potential and
cytochrome c release in cultured hepatocytes. Nevertheless, because the caspase-3
inhibitor Ac-DEVE-CHO also abolished the mitochondrial depolarization, the authors
concluded that the inhibition of cytochrome c release and loss of mitochondrial
transmembrane potential by NO in hepatocytes were due to the inhibition of caspaseactivation (Li et al., 1999). In contrast, the present finding that cyclosporin A abolished
cocaine-induced activation of caspase-9 and caspase-3 strongly suggests that loss of
mitochondrial transmembrane potential is required for cocaine-mediated caspase
activation in BCAECs. A recent study examined the effects of NO on the mitochondrial
permeability transition pore (FTP) by exposing isolated rat liver mitochondria to NO
released from NONOate NO donor, and demonstrated that NO reversibly inhibited FTP
opening and cytochrome c release at physiological levels of NO, while accelerated FTP
opening at pathophysiological NO levels (Brookes et al., 2000). It is tempting to
speculate that NO-inhibited caspase activation induced by cocaine in the present study
may be mediated by both direct S-nitrosylation of caspases and indirect inhibition of
cytochrome c release in BCAECs. Given that caspase-9 is upstream of caspase-3 in the
caspase cascade in BCAECs, the possibility that DETA-NO-induced inhibition of
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caspase-3 was mediated in part by its inhibition of caspase-9 cannot be ruled out in the
present study.
Our previous study has demonstrated that cocaine decreases Bcl-2 protein levels,
which is the upstream signal for cytochrome c release from the mitochondria in BCAECs
(He et al., 2000b). Bcl-2 proteins are predominantly localized to the outer mitochondrial
membrane, and mediate antiapoptotic effects by stabilizing the mitochondrial membrane
and inhibiting cytochrome c release (Adams and Cory, 1998; Reed, 1997). The finding that
the cocaine-induced decrease in Bcl-2 proteins was partially blocked by caspases inhibitors
in the present study suggests that the Bcl-2 protein is not only an upstream inhibitory
signal of caspases but also a downstream substrate of caspases. The results also suggest
that the activated caspases act as amplifiers in the positive feed back loop in cocaineinduced apoptosis. This finding is in agreement with previous studies showing that the
proteolytic cleavage of Bcl-2 by activated caspases plays a key role in the amplification
of pro-apoptotic signaling (Cheng et al., 1997; Kirsch et al., 1999). In a previous study,
Kim et al. (1998) demonstrated that the NO donor SNAP inhibited Bcl-2 cleavage in
hepatocytes by inhibiting caspases through a mechanism consistent with S-nitrosylation
of the protease. In contrast, the present study demonstrated that DETA-NO had no effect
on cocaine-induced Bcl-2 cleavage in BCAECs despite the fact that it blocked cocaineinduced activation of caspase-3 and caspase-9. The reasons for the difference between
the present study and the previous one (Kim et al., 1998) are not clear at present, but may
be due to the differences in the cell types (endothelial cells vs hepatocytes) and/or the NO
donors (DETA-NO vs SNAP) used. The present finding suggests that exogenous NO
may actually promote Bcl-2 cleavage in endothelial cells. Indeed, it has been
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demonstrated in neuronal cells that NO caused a decrease in Bcl-2 proteins (Matsuzaki et
ah, 1999; Tamatani et al, 1998). However, because NO inhibited downstream caspase
activation in the present study, it blocked cocaine-induced apoptosis in BCAECs.
Unlike Bcl-2 proteins, cocaine showed no effect on Bax protein levels in
BCAECs (He et ah, 2000b). It has been demonstrated that Bax proteins are predominantly
localized in the cytosol, and upon activation, translocate to the mitochondria and mediate
cytochrome c release (Adams and Cory, 1998; Gross et al., 1998; Marzo et al., 1998;
Nomura et al., 1999; Putcha et al., 1999). The present finding that cocaine induced Bax
translocation from cytosol to mitochondria suggests an important role for Bax in cocainemediated apoptosis in BCAECs. Neither the caspase inhibitor nor DETA-NO had an effect
on cocaine-induced Bax translocation, suggesting that Bax is an upstream signal of caspase
activation, and NO-mediated inhibition of caspase activation occurs downstream of Bax
translocation.
Taken together, as shown in Fig. 10, we speculate that cocaine exerts its cytotoxic
effects on endothelial cells through 3 mechanisms: 1) cleavage of Bcl-2, 2) induction of
Bax translocation, and 3) attenuation of NO production. Although the mechanisms
underlying cocaine-induced Bcl-2 cleavage in BCAECs are not clear at present,
decreased Bcl-2 is likely to promote the translocation of Bax to the mitochondria, leading
to the release of cytochrome c and subsequent activation of the caspase cascade (Murphy
et al., 2000; Nomura et al.,1999; Putcha et al., 1999). Once the mitochondria apoptotic
pathway is activated, the death signal is further amplified by the cleavage of Bcl-2 by the
activated caspases. This positive feedback loop ensures the cell’s demise. We speculate
that NO interacts with the mitochondria apoptotic pathway at two different levels: the
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mitochondria level and the caspase level. By inhibiting mitochondrial FTP opening and
caspase activation, NO protects endothelial cells from apoptotic cell death. The finding
that Fas denitrosylates endogenous procaspase-3 which was normally S-nitrosylated by
endogenous NO (Mannick et al., 1999) suggests that NO-mediated S-nitrosylation of
procaspases may occur in the resting state as a mechanism to inhibit caspase activation.
Along with this finding, we speculate that cocaine-induced activation of caspases may be
in part due to the denitrosylation of procaspases caused by the attenuation of NO. It
remains unclear whether cGMP plays a role in the antiapoptotic effect of NO.
Considering the multiple biological function of NO and its capacity of rapid diffuse
intracellularly and intercellularly, it is likely that the cytotoxicity of cocaine is far more
complicated in vivo and a variety of mechanisms may be involved.
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Figure 1. Effect of cocaine on NO release in bovine coronary artery endothelial cells
(BCAECs). BCAECs were treated with control medium or medium with 100 fiM cocaine
for the indicated time periods. NO (measured as NOx) in the medium was measured by
the chemiluminescence method as described in the Methods. Data are means ± S.E.M. of
six experiments. *p< 0.05 vs. the control.
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Figure 2. Effect of DETA-NONOate on cocaine-induced cell death in bovine
coronary artery endothelial cells (BCAECs). BCAECs were treated with control
medium or medium with 100 }j,M cocaine (COC) in the presence or absence of 20 pM
DETA-NONOate (DETA-NO) for the indicated time periods. Cell viability was
determined by MTT method. Data are means ± S.E.M. of ten experiments. Data were
analyzed by full factorial two-way ANOVA with Bonferroni correction. Cocaine vs.
control,/? < 0.001; DETA-NO vs. control,/? = 0.134; DETA-NO + cocaine vs. control,/?
= 0.074.
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Figure 3. Effect of NO donors on cocaine-induced apoptosis in bovine coronary
artery endothelial cells (BCAECs). BCAECs were treated with control, medium or
medium with 100 pM cocaine (COC) in the presence or absence of DETA-NO (20 pM),
decomposed DETA-NO (20 pM), and SNAP (10 and 100 pM) for 24 hours. Cells were
then stained with DNA binding florescence dye Hoechst 33258 and nuclear morphology
was examined by florescence microscopy. Panel A shows cocaine-induced nuclear
morphological changes in BCAECs. The arrows show condensed, coalesced, and
segmented apoptotic nuclei, a. control; b. 100 pM cocaine; c. 100 pM cocaine + 20 pM
DETA-NO; d. 100 pM cocaine + 20 pM decomposed DETA-NO. bar, 20 pm. Panel B
shows the quantitative results. Data are means ± S.E.M. of four experiments. * /? < 0.05
vs. the control. + p< 0.05 vs. cocaine alone.
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Figure 4. Effect of L-NAME on cell viability of bovine coronary artery endothelial
cells (BCAECs). BCAECs were treated with control medium or medium with 100 juM LNAME and 100 \xM cocaine, respectively, for the indicated time periods. Cell viability
was determined by MTT method. Data are means ± S.E.M. of ten experiments. Data
were analyzed by full factorial two-way ANOVA with Bonferroni correction. Cocaine
vs. control,/? < 0.001; L-NAME vs. control,/? < 0.001; L-NAME vs. cocaine,/? < 0.001.
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Figure 5. Effects of cyclosporin A and caspase inhibitors on cocaine-induced
caspase-3 activation in bovine coronary artery endothelial cells (BCAECs). BCAECs
were treated with 100 pM cocaine (COC) in the absence or presence of cyclosporin A
(CSA, 1 pM), Ac-DEVE-CHO (DEVD-CHO, 100 pM), and Z-LEHD-FMK (LEHDFMK, 20 pM), respectively, for 24 h. The caspase-3 activity was determined using
colorimetric caspase activity detection kit as described in the Methods. Data are means ±
S.E.M. of six experiments. */? < 0.05 vs. the control.
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Figure 6. Effects of cyclosporin A and caspase inhibitors on cocaine-induced
caspase-9 activation in bovine coronary artery endothelial cells (BCAECs). BCAECs
were treated with 100 pM cocaine (COC) in the absence or presence of cyclosporin A
(CSA, 1 pM), Ac-DEVE-CHO (DEVD-CHO, 100 pM), and Z-LEHD-FMK (LEHDFMK, 20 pM), respectively, for 12 h. The caspase-9 activity was determined using
colorimetric caspase activity detection kit as described in the Methods. Data are means ±
S.E.M. of five experiments. * /? < 0.05 vs. the control, + p< 0.05 vs. cocaine.
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Figure 7. Effect of DETA-NONOate on cocaine-induced activation of caspase-3 and
caspase-9 in bovine coronary artery endothelial cells (BCAECs). BCAECs were
treated with 100 pM cocaine (COC) in the absence or presence of 20 pM DETANONOate (DETA-NO). The activities of caspase-9 and caspase-3 were determined using
colorimetric caspase activity detection kits as described in the Methods. Data are means
± S.E.M. of six (caspase-3) and five (caspase-9) experiments. */? < 0.05 vs. the control.
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Figure 8. Effects of DETA-NONOate and caspase inhibitors on cocaine-induced
cleavage of BcI-2 in bovine coronary artery endothelial cells (BCAECs). BCAECs
were treated with 100 pM cocaine (COC) in the absence or presence of DETA-NONOate
(DETA-NO, 20 pM), Ac-DEVD-CHO (DEVD, 100 pM), Z-LEHD-FMK (LEHD, 20
pM), respectively, for 48 h. Proteins were separated on 12% SDS-PAGE, and Bcl-2 was
detected by Western blotting using monoclonal antibody. Actin was used as a loading
control. The upper panel shows the representative Western immunoblots. The lower
panel shows the quantitative results. Data are expressed as percent of the control levels,
and are means ± S.E.M. of four experiments. * /? < 0.05 vs. the control, + p < 0.05 vs.
cocaine.
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Figure 9. Effects of DETA-NONOate and caspase inhibitor on cocaine-induced
translocation of Bax in bovine coronary artery endothelial cells (BCAECs).
BCAECs were treated with 100 pM cocaine (COC) in the absence or presence of DETANONOate (DETA-NO, 20 pM) and Ac-DEVD-CHO (DEVD, 100 pM), respectively, for
48 h. The cytosolic and mitochondrial fractions were separated as described in the
Methods. Proteins from each fraction were separated on 12% SDS-PAGE, and Bax was
detected by Western blotting using monoclonal antibody. The upper panel shows the
representative Western immunoblots. The lower panel shows the quantitative results.
Data are expressed as percent of the control levels, and are means ± S.E.M. of four
experiments. *p< 0.05 vs. the control.
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Figure 10. Mechanisms of cocaine-induced apoptosis in bovine coronary artery
endothelial cells (BCAECs). Cocaine-induced cleavage of Bcl-2 proteins and
translocation of Bax from the cytosol to the mitochondria may serve as upstream signals
of cytochrome c release and subsequent activation of caspase-9 and caspase-3, leading to
apoptosis. Activated caspases produce positive feedback to further cleave Bcl-2 and
ensure the cell’s demise. NO interacts with the mitochondrial apoptotic pathway at two
levels. At mitochondrial level, physiological NO may inhibit mitochondrial FTP opening
and cytochrome c release. At caspase level, NO inhibits caspase activation by Snitrosylation. Cocaine decreases NO in BCAECs leading to an attenuation of protective
effect of NO and a facilitation of activation of the caspase cascade. The mechanisms of
cocaine-induced cleavage of Bcl-2 and translocation of Bax remain to be determined.
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CHAPTER 5
EFFECTS OF COCAINE ON NITRIC OXIDE PRODUCTION IN BOVINE
CORONARY ARTERY ENDOTHELIAL CELLS

Jiale He, Yuhui Xiao and Lubo Zhang

This chapter was submitted for publication to the Journal of Cardiovascular
Pharmacology

149

Abstract
Cocaine increases the sensitivity of coronary artery to endogenous vasoactive
substances. To start to understand the potential mechanisms, the present study examined
the effect of cocaine on nitric oxide (NO) release in bovine coronary artery endothelial
cells (BCAECs). In the absence of cocaine, basal NO release from BCAECs continued to
accumulate in the medium over the period from 6 to 72 hr. Cocaine significantly
decreased NO release at each time point of the study. At 48-hr treatment, cocaine (3 to
30 pM) produced a dose-dependent decrease in NO release in BCAECs. In accordance
with its inhibition of NO release, cocaine decreased eNOS protein levels in BCAECs in a
dose-dependent manner. In addition to the prolonged effect, cocaine pretreatment for 1
hr significantly decreased basal and ATP-induced NO release in BCAECs. Whereas
cocaine did not affect basal levels of free intracellular calcium concentration in BCAECs,
it significantly decreased ATP-induced elevation of intracellular calcium and increased
its time lag to reach the peak. A quantitative approach by immunofluorescence
microscopy revealed that cocaine significantly increased eNOS localized at the cell
membrane in BCAECs. Collectively, we conclude that cocaine inhibits NO release in
BCAECs by decreasing intracellular calcium concentration, increasing inactive state of
eNOS, and decreasing eNOS protein levels.
Introduction
The complications of cocaine abuse affect every system of the body (Benowitz,
1992). The multifactorial effects of cocaine on the cardiovascular system often contribute
to its sympathomimetic action. It has been suggested that the coronary artery is more
sensitive to endogenous vasoactive substances after chronic cocaine abuse (Jones et al.,
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1990). Cocaine abuse has been reported to cause an increase in coronary artery
vasoconstriction (Vongpatanasin et ah, 1997) and recurrent coronary vasoconstriction
(Brogan et ah, 1992), a decrease in coronary blood flow (Miao, 1996), and an increase in
myocardial ischemia and infarction (Pitts et ah, 1993). Although acute cocaine use is
typically considered as a risk factor for acute cardiac events, chronic use may contribute
to the development or rapid progression of coronary artery diseases (Wilson, 1998; He et
ah, 2000a,b). Recent studies have suggested that the endothelium-dependent
vasorelaxation is impaired in long-term cocaine users (Wang et ah, 1995; Havranek et ah,
1996). The endothelium plays an important role in modulating coronary vascular tone by
releasing nitric oxide (NO), and inhibition of NO generation from coronary endothelium
results in an increase in coronary vascular resistance and attenuation of flow-induced
coronary vascular dilation (Chu A et ah, 1991). Abnormal coronary endothelial function
could contribute to atherosclerosis, thrombosis, focal vasospasm and myocardial
ischemia, all of which have been demonstrated in cocaine users with myocardial
infarction. (Havranek et ah, 1996).
NO is synthesized in the endothelium by endothelial isoform NO synthase
(eNOS). In contrast to the other NOS isoforms, eNOS binds to the particular subcellular
fractions. It has been suggested that the eNOS enzyme is tonically inhibited by its
protein-protein interaction with caveolin, the resident scaffolding protein in
plasmalemmal carveolae (Michel, 1999; Michel et ah, 1997; Ju et ah, 1997). The
dynamic equilibrium of eNOS plasmalemmal membrane targeting in cultured endothelial
cells is exquisitely sensitive to changes in intracellular calcium concentration. It has been
demonstrated that agonist-induced activation of eNOS is mediated by translocation of
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eNOS from plasmalemmal membrane to intracellular sites close to the nucleus, and the
translocation is completely abrogated by chelation of intracellular Ca (Prabhakar et ah,
1998; Michel, 1999).
To our knowledge, there is no study yet to directly examine the effect of cocaine
on NO release in the endothelium. The specific objectives of this study therefore were to
determine in bovine coronary artery endothelial cells whether cocaine: 1) decreased NO
production, 2) inhibited intracellular Ca2+ mobilization, 3) changed dynamic equilibrium
of eNOS distribution between plasmalemmal membrane and intracellular sites close to
the nucleus, and 4) decreased eNOS protein levels.
Materials and Methods
Materials. Cocaine, phosphate-buffer saline (PBS), ATP, anti-actin monoclonal
antibody were purchased from Sigma (St Louis, MO). Vanadium (III) chloride was from
Aldrich Chem. Co. (Milwaukee, WI). Fetal bovine serum was purchased from Hyclone
Laboratories (Logan, UT). Protein assay kit was from Bio-Rad (Hercules, CA). Purified
anti-eNOS antibody was from Transduction Laboratories (Franklin Lakes, NJ).
Horseradish peroxidase (HRP)-conjugated anti-mouse IgG was from Amersham Life
Science (Clearbrook, IL). Anti-mouse IgG-FITC was from Santa Cruz Biotechnology
(Santa Cruz, CA). Prestained protein molecular weight standards was from GibcoBRL
(Grand Island, NY). Fura-2 AM was from Molecular Probes (Eugene, OR)
Cell Culture. Bovine coronary artery endothelial cells (BCAECs) were obtained
from Cell Applications, Inc. (San Diego, CA). Cells were grown in the complete medium
of Dulbecco’s Modified Eagle’s Medium (DMEM, Mediatech Cellgro Inc., VA) with
glucose (4.5 g/L), 15% fetal bovine serum, 100 U/ml penicillin, 100 p,g/ml streptomycin,
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and were incubated at 37 °C in a humidified incubator with 5% CO2,95% air. Cells were
used for the experiments at the fifth and sixth passages. Cell numbers were determined
using a hemacytometer and cell viability determined using trypan blue exclusion.
Measurement ofNOx NO was measured by chemiluminescence method as
described previously (Yang et al., 2000). Briefly, cells grown on 6-well dishes were
treated with different drugs and medium were collected for assay. Because of the
instability of NO in physiological solution, most of NO is rapidly converted to nitrite
(NO2 ) and further to nitrate (NO3’). Nitrite and nitrate are relatively stable in the
solution, and are readily reduced back to NO in vanadium (III)/HC1 solution. The
samples (100 pi) taken from the medium were injected into the gas purge vessel
containing 5 ml vanadium (III)/HC1 and allowed to react for 1 min to reduce
nitrate/nitrite in the sample back to NO. To achieve high reducing efficiency, the
reduction was performed at 90 °C. NO in the sample was then “stripped” into the head
space of the gas purge vessel by bubbling it with helium (12 ml/min) for 60 sec. NO in
the head space was drawn into a NO Analyzer (Model 270B, Sievers Instruments, Inc.,
Boulder, CO) and mixed with ozone (O3) in front of a cooled Hamamatsu, red-sensitive
photomultiplier tube. Signals from the detector were analyzed by an on-line computer as
area under the peak. The measurement reflected the combined concentrations of nitrate,
nitrite, and nitric oxide (NOx) of each sample, which was calculated from a standard
curve of 10 to 1000 picomoles nitrate run in each assay.
Measurement of intracellular free Ca2+ concentration ([Ca2Jr]j). [Ca2+]/ was
measured in single cells as previously described (Yang et al., 2000). Briefly, the cells
were loaded with fura-2 by incubation with 5 pM fura-2/AM for 45 min at 37 °C in the
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loading buffer containing NaCl 125 mM, KC1 5 mM, KH2PO4 1 mM, MgS04 1 mM,
CaCl2 2 mM, HEPES 25 mM (pH 7.4), D-glucose 6 mM, neostigmine 10 nM, Cremophor
EL 0.02%. The cells were then washed three times and incubated in Krebs’ solution for
15 min at 37 °C to allow for complete hydrolysis of the ester groups by endogenous
esterases. Fura-2 fluorescence was monitored photometrically at an emission wavelength
of 510 nm in a single cell mounted on a Nikon Diaphot inverted microscope illuminated
alternatively with 340-nm and 380-nm light using an InCyt Im2 Intracellular Imaging
System (Intracellular Imaging Inc., Cincinnati, Ohio). Photon counting was performed
by a photomultiplier tube positioned so that the field of interest may be restricted by
thresholding shutters. Data acquisition was accomplished with the software that controls
a light chopper to alternate excitation wavelengths during rationing operations.
Intracellular free Ca2+ concentration ([Ca2+],) was calculated in real time from a standard
curve established for the same settings using buffers of known Ca2+concentrations.
Immunolabeling of eNOS. BCAECs were cultured onto glass coverslips, and
serum was withdrawn from the medium 24 hr before cocaine treatment. Subcellular
eNOS distribution in BCAECs was immunolabelled as described previously (Goetz et al.,
1999; Prabhakar et al., 1998). Briefly, after cocaine treatment for 1 hr, cells were fixed in
2% freshly prepared paraformaldehyde for 10 min at room temperature and
permeabilized in PBS with 0.1% Triton X-100 and 0.1% bovine serum albumin for 5 min
at room temperature. Cells were then incubated in PBS containing 10% bovine calf serum
overnight at 4 °C, treated with anti-eNOS monoclonal antibody at 1:250 dilution for 60
min at room temperature, washed with PBS three times for 5 min each, and incubated
with Anti-mouse IgG-FITC antibody at 1:200 dilution for 60 min at room temperature.
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After washing with PBS three times for 10 min each, the coverslips bearing the cells was
mounted on a microscope slide and visualized by fluorescence microscope. Quantitative
analysis of eNOS immunofluorescence was performed as previously described (Goetz et
al., 1999; Prabhakar et ah, 1998). Since the eNOS immunofluorescence at the membrane
was usually nonuniform in each individual cell, a cell was assigned as plasmalemmal
membrane bound eNOS-state when even a small patch of eNOS was detected at
plasmalemmal membrane (State A). On the other hand, if the eNOS
immunofluorescence was visualized only in the cytosol, the cell was assigned as
cytosolic eNOS-state (State C). If the eNOS immunofluorescence was visualized in both
the plasmalemmal membrane and the cytosol then the cell was assigned as mixed eNOSstate (State B). For each experiment, the pictures of cells taken under fluorescent
microscopy in 9 randomly selected high power fields were analyzed (approximately 200
cells /coverslip). The percentage of each eNOS state was compared between the control
and cocaine-treated samples. Each experiment was conducted at least three times.
Western analysis of eNOS. After the treatment, the endothelial cells were
solubilized by sonication in lysis buffer (NaCl 150 mM, Tris HC1 50 mM, EDTA 10 mM,
Tween 20 0.1%, P-mercaptoethanol 0.1%, phenylmethylsulfonyl fluoride 0.1 mM,
leupeptin 5 pg/ml, and aprotinin 5 pg/ml, pH 7.4). After centrifugation, protein was
quantified in the supernatant by the method of Bradford (1976). Samples with equal
protein (10 pg) were loaded on a 7.0 % polyacrylamide gel with 0.1% sodium dodecyl
sulfate (SDS) and were separated by electrophoresis at 100 V for 2 hours. Proteins were
then transferred onto immobilon P membrane at 30 V for 30 min at room temperature
using a semi-dry blotter (Bio-Rad). The immobilon P membrane was probed by mouse
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monoclonal antiserum for eNOS (1:750) obtained from Transduction Laboratories
(Lexington, KY). The secondary antiserum was horseradish peroxidase-conjugated goat
anti-mouse (1:1,000) obtained from Amersham (Arlington Heights, IL). Proteins were
visualized with enhanced chemiluminescence (ECL) reagents (Amersham), and the blots
were exposed to hyperfilm. Results were quantified by scanning densitometer (model 670,
Bio-Rad) and expressed as percent of the control values.
Data analysis. Data were presented as the mean ± SEM. Statistical analyses were
performed by paired Student t-test as well as one-way ANOVA followed by NewmanKeuls post hoc tests respectively. Differences were considered significant at P < 0.05.
Results
Effect of cocaine on NO release. The effect of cocaine on ATP-induced NOx
release in BCAECs is shown in Fig. 1. Cells were treated with control medium or
medium with 100 pM cocaine for 1 hr and were then challenged with different doses of
ATP for 1 hr. NO (measured as NOx) in the medium was assayed by chemiluminescence
method. As shown in Fig. 1, ATP (1-100 pM) produced concentration-dependent
increases in NOx release in both control and cocaine-treated cells. The ATP-induced NOx
release was significantly decreased in cocaine-treated than control cells. The effect of
prolonged cocaine treatment on basal NOx release in BCAECs is shown in Fig. 2. The
cells were treated with control medium or medium with 100 pM cocaine for up to 72 hr.
Over the 72-hr period of cocaine treatment, basal NOx continued to accumulate in the
medium. As shown in Fig. 2, cocaine significantly decreased NOx release from BCAECs
at each time point of the study. At 48-hr treatment, cocaine (3, 10, 30 pM) produced a
dose-dependent decrease in basal NOx release in BCAECs (Fig. 3).
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Effect of cocaine on Ca2+ mobilization. Intracellular free Ca2+ concentration
([Ca2+];) in BCAECs was examined in single cells loaded with Fura-2. Fig. 4 shows
representative single cell fluorescence tracing stimulated with 30 pM ATP. As shown in
the figure, ATP induced a rapid nse m [Ca ]; in BCAECs, which was reflected by an
increase in Fura-2 fluorescence intensity at 340 nmex and a decrease in the intensity at
2_j_

380 nmex. The maximal [Ca ]; response was reached within 20 seconds followed by a
decline to a steady state above the baseline level (Fig. 4). Unlike ATP, cocaine (30 pM)
did not change basal [Ca2+]/ in BCAEC (38.47 ± 4.25 nM vs. 40.99 ± 5.11 nM). Fig. 5
shows the real time effect of cocaine on ATP-induced [Ca2+]j response in BCAECs. As
shown in Fig. 5, 30 pM ATP caused a [Ca ]i spike followed by a plateau phase in a
single endothelial cell (Fig. 5A). After washing and recovery, the same cell was
pretreated with 30 pM of cocaine for 15 min, and then challenged again with 30 pM ATP
(Fig. 5B), and the [Ca ]i peak induced by ATP was greatly reduced. The response to
ATP was completely recovered after the removal of cocaine (Fig. 5C). Quantitative
analysis of the data revealed that the [Ca2+]i peaks induced by 30 pM ATP in the absence
and presence of cocaine were 170.3 ± 45.9 nM and 92.8 ±31.3 nM, respectively (P <
0.05, paired t-test) (Fig. 6A). In addition to its effect on the peak [Ca2+]i response induced
by ATP, cocaine significantly increased the time lag of ATP-stimulated [Ca2+]i response
in BCAECs. As shown in Fig. 6B, the time required between ATP administration and the
peak [Ca2+]i response in the absence and presence of cocaine was 11.3 ± 2.0 sec and 25.1
± 4.5 sec, respectively (P < 0.05, paired t-test).
94-

Effect of cocaine on eNOS translocation. eNOS is a Ca -dependent enzyme
and is subject to a complex pattern of intracellular regulation, its activation includes the
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reversible translocation from plasmalemmal membrane to intracellular sites close to the
nucleus. In resting cells, eNOS is tonically inhibited by its binding to caveolin at
plasmalemmal caveolae. The dynamic distribution of eNOS between plasmalemmal
membrane and the intracellular sites is exquisitely sensitive to changes in intracellular
calcium concentration. To study the effect of cocaine on eNOS translocation, we first
pretreated the cells with serum-free medium for 24 hr, followed by 1 hr cocaine (100
pM) treatment. Fig. 7 shows the typical photomicrographs of BCAECs processed for
immunolabeling of eNOS. The cellular distribution of eNOS immunoreactivity exhibited
considerable heterogeneity. As shown in Fig. 7, three distribution states of eNOS were
noted in BCAECs: plasmalemmal membrane bound eNOS-state (State A), cytosolic
eNOS-state (State C), and mixed eNOS-state (State B). In the absence of cocaine, about
70% of cells showed eNOS in the cytosolic fraction (State C). Cocaine treatment for 1
hr significantly increased membrane bound eNOS (State A) but decreased eNOS in State
B and C (Fig. 8).
Effect of cocaine on eNOS protein levels. Fig. 9 shows the effect of prolonged
cocaine treatment on eNOS protein levels in BCAEC. The representative Western
immunoblot showed that the monoclonal antibody for eNOS detected a single band at the
expected size of 135 kD (Fig. 9, upper panel). Cocaine (10, 30, 100 pM) treatment for 48
hr produced a dose-dependent decrease in eNOS protein levels in BCAECs. Quantitative
densitometry for four independent experiments revealed that cocaine produced more than
70% decrease in eNOS protein levels in BCAECs (Fig. 9, lower panel).
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Discussion
The present report investigated the inhibitory effects of cocaine on NO production
and the potential underlying mechanisms in cultured bovine coronary artery endothelial
cells. The major findings are as follows: 1) both acute and prolonged cocaine treatments
decrease NO release, 2) short term cocaine pretreatment inhibits intracellular Ca2+
mobilization, 3) cocaine drives eNOS translocation to an inactive plasmalemmal
membrane binding state, 4) prolonged cocaine treatment decreases eNOS protein levels.
Previous studies have suggested that the endothelium-dependent vasorelaxation is
impaired in long-term cocaine usage (Wang et al., 1995; Havranek et al., 1996).
Experimental results also showed stripping the endothelial layer from isolated arteries
abolished the vasoconstrictive effect of cocaine (Mo et al., 1998). These studies suggest
that the action of cocaine be mediated at least in part by inhibiting NO. The present study
demonstrated for the first time that cocaine indeed inhibited NO release in coronary
artery endothelial cells. The finding that the basal release of NO was dose-dependently
decreased with the exposure to cocaine for 48 hr suggests that long term cocaine action
may interfere with the intrinsic endothelial NO synthesis system. Similar findings were
obtained in human coronary artery endothelial cells exposed to erythropoietin (Wang et
al., 1999). Further experiments revealed that the fall in NO production was accompanied
by a parallel concentration dependent reduction in eNOS protein levels in BCAECs after
exposure to cocaine for 48 hr. Because eNOS is the enzyme responsible for NO
production in endothelial cells, the decreased expression of the protein may account for
the corresponding decrease of basal NO release in prolonged cocaine treatment in these
cells. Previous studies have suggested that decreased eNOS expression is associated with
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endothelial dysfunction in a verity of diseases (Agnoletti et al., 1999; Zhou et al., 2000;
Toporsian et al., 2000). Our current results provide a partial mechanistic explanation for
coronary artery vasospasm and recurrent coronary vasoconstriction and ischemia in
chronic cocaine abusers because the downregulation of eNOS may form the pathological
basis of the progression of coronary artery diseases. Moreover, synthesis of both
endothelin-1 and thromboxane A2 have been reported to be under the negative regulatory
influence of NO (Goligorsky et al., 1994; Wade et al., 1997). Accordingly, cocaineinduced inhibition of eNOS expression and decrease in NO release may play an
additional role in the alteration in endothelial function through the removal of an inhibitor
of vasoconstrictors.
It is now well established that the endothelium-dependent vasodilation produced
9-4-

by vasoactive agents such as ATP is through the increase of [Ca ]j, stimulation of the
calcium-dependent eNOS, and leading to the release of NO in endothelial cells (for
review see Tran et al., 2000; Himmel et al., 1993). Intravenous infusion of ATP is often
used to induce coronary vasodilation in patients unable to perform exercise stress tests for
201T1 scintigraphy (Faulds et al., 1991). The effect of extracellular ATP occurs via the
activation of purinoceptors of the P2y subtype on endothelial cells (Martin et al., 1985;
Yang et al., 1998). In the present study, we have shown that ATP induces an increase in
NO production in BCAECs in a dose-dependent manner. Similar finding was obtained
in human coronary artery endothelial cells (Yang et al., 2000). The ATP-stimulated rise
in NO release was significantly reduced by a short term treatment of the cells with
cocaine. In accordance with its inhibition of ATP-induced NO production, cocaine
suppressed the ATP-induced [Ca2+]j transient and delayed the ATP-induced [Ca2+]i peak.
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Similar studies were found in other group (Kimura et al, 2000). These data suggest that
the inhibitory effect of cocaine on ATP-induced NO production may be due to the
inhibition of [Ca2+]j transient. Meanwhile, the inhibition of [Ca2+]j transient by cocaine
was reversed by washing out the drug, indicating that the short term effects of cocaine
were not associated with permanent endothelial cell damage. Previous studies on
myocytes have suggested several possible sites at which cocaine may interfere with the
[Ca2+]i transient (Huang et al., 1997; Przywara et ah, 1997; Stewart et ah, 1991): 1)
inhibition of sarcolemmal Na channels, 2) reduction of the slow inward Ca

currents by

direct interference with the sarcolemmal voltage-sensitive calcium channels, 3) inhibition
of calcium entry via reversal of Na+-Ca2+ exchange, and 4) alteration of Ca2+ release from
the sarcoplasmic reticulum. The results of these actions of cocaine would lead to
decreased Ca2+ entry to the sarcoplasmic reticulum and decreased Ca2+ load in
sarcoplasmic reticulum in cardiomyocytes (Renard et ah, 1994). It has been suggested
that different Ca2+ pools may exist in a number of cells and participate in a coordinated
fashion in Ca2+ release and subsequent Ca2+ wave and oscillations (Meldolesi et ah,
1990; Jacob, 1991). Many studies have demonstrated in endothelial cells that the initial
component of ATP-induced [Ca2+]j transient results from release of Ca2+ from
endoplasmic reticulum, whereas the delayed component contributing to the plateau phase
is dependent on Ca2+ influx from the extracellular space (for review, see Himmel et ah,
1993). In the present study, we have found that cocaine decreases the initial component
of ATP-induced [Ca2+]j transient without affecting the plateau phase. Taken together, we
speculate that cocaine may act through one or both of the following mechanisms: 1)
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inhibiting Ca2+ entry into the endoplasmic reticulum resulting in a decrease in Ca2+ load
in the endoplasmic reticulum, 2) decreasing Ca release from the endoplasmic reticulum.
Although the mechanisms of decreased NO production by short term cocaine
treatment are not entirely clear at present, our finding that cocaine drives eNOS
redistribution and increases plasmalemmal membrane binding state of eNOS in BCAECs
suggests that cocaine may decrease NO synthesis by interfering with the eNOS
activation/deactivation cycle. It has been demonstrated that the dynamic equilibrium of
eNOS plasmalemmal membrane targeting in cultured endothelial cells is exquisitely
sensitive to changes in intracellular calcium concentration, and translocation of eNOS
from the plasmalemmal membrane to intracellular sites close to the nucleus plays a key
role in the process of activation of eNOS (Michel et al., 1997; Prabhakar et al., 1998;
Michel, 1999). The heterogeneity of cellular distribution of eNOS observed in the
present study is in agreement with previous finding in bovine aortic endothelial cells
(Prabhakar et al., 1998). Unlike the previous study in which -60-80% untreated
endothelial cells showed prominent eNOS immunostaining at the cell periphery
(Prabhakar et al., 1998), the present study demonstrated most of eNOS immuno staining
at perinuclear sites (-70%). This may be due in part to exposure of BCAECs to serumfree medium in the present study. Similar findings were reported in bovine aortic
endothelial cells (Venema et al., 1996; 1997). Importantly, the present study
demonstrated that short term cocaine treatment significantly increased plasmalemmal
membrane binding state of eNOS in BCAECs as compared to the untreated cells. Since
the eNOS enzyme activity is suppressed by the association between eNOS and caveolin
in the plasmalemmal membrane, the present finding suggests that cocaine-induced
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decrease in NO production may be mediated in part by its induction of eNOS
translocation to an inactive state in BCAECs. Whereas the molecular mechanisms
underlying the cocaine-mediated eNOS translocation remain unclear, it may be due to
inhibitory effects of cocaine on Ca2+ mobilization as demonstrated in the present study
and its effect on the dynamic heterogeneity of lipid membranes (Jorgensent et ah, 1993).
In summary, we demonstrated that both short-term and prolonged cocaine
treatments decrease NO release in bovine coronary artery endothelial cells. Multiple
mechanisms may be involved in the inhibitory effect of cocaine. For the short-term
2“h

effect, cocaine decreases intracellular Ca mobilization and increases translocation of
eNOS to plasmalemmal membrane inactive state. For the long-term effect, cocaine
decreases eNOS protein levels. These findings should provide a basis to understand the
mechanisms underlying the recurrent of ischemia remote from acute administration and
the rapid progression of coronary artery diseases in chronic cocaine abusers, and may
explain the acute cocaine-induced coronary vasospasm from another perspective.
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Figure 1. Effect of cocaine on ATP-induced NO release in bovine coronary artery
endothelial cells (BCAECs). BCAECs were pretreated in the absence and presence of
cocaine (100 pM) for 1 hr, followed by stimulation with indicated concentrations of ATP
for 1 hr. NOx in the medium was measured by chemiluminescence method as described
in the Methods. Data are means ± S.E.M. of twelve experiments. * P < 0.05 vs. the
control.
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Figure 2. Time effect of cocaine on NO release in bovine coronary artery
endothelial cells (BCAECs). BCAECs were treated with control medium or medium
with 100 j-iM cocaine for the indicated time periods. NOx in the medium was measured
by the chemiluminescence method as described in the Methods. Data are means ± S.E.M.
of six experiments. * P < 0.05 vs. the control.
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Figure 3. Dose-dependent effect of cocaine on NO release in bovine coronary artery
endothelial cells (BCAECs). BCAECs were treated in the absence and presence of
cocaine (3, 10, 30 pM) for 48 hr. NOx in the medium was measured by the
chemiluminescence method as described in the Methods. Data are means ± S.E.M. of six
experiments. * P < 0.05 vs. the control.
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Figure 4. Effect of ATP on single cell intracellular free calcium concentration
([Ca2+]i) in bovine coronary artery endothelial cells (BCAECs). Representative
fluorescence tracings of fura-2 loaded single cell in response to 30 pM ATP stimulation.
A. Fluorescence intensity recorded at excitation wavelength of 340 run. B. Fluorescence
intensity recorded at excitation wavelength of 380 run. C. The intracellular Ca2+ transient
calculated by the ratios of F340/380 as described in the Methods.
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Figure 5. Effect of cocaine on ATP-induced intracellular calcium changes in bovine
coronary artery endothelial cells (BCAECs). BCAECs were loaded with Fura-2. The
tracings show the real time-drug effect of single cells in response to 30 pM ATP. A.
ATP caused a [Ca ]j spike followed by a plateau phase in a single endothelial cell. B.
After washing and recovery, the same cell was pretreated with 30 pM cocaine for 15 min,
and then stimulated with 30 pM ATP. C. After wash out of cocaine, the cell was
recovered and stimulated with 30 pM ATP again.
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Figure 6. Effect of cocaine on ATP-induced intracellular calcium changes in bovine
coronary artery endothelial cells (BCAECs). Quantitative analysis of ATP-induced
[Ca2+]i changes in the absence and presence of cocaine (30 pM). A. A peak [Ca2+]j = peak
[Ca ]j - basal [Ca ]j B. A time = peak time - the time of drug administration. Data are
means ± S.E.M. of eight experiments. * P < 0.05 vs. ATP alone by paired t-test.
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Figure 7. Distribution of eNOS in bovine coronary artery endothelial cells
(BCAECs). eNOS localization states in BCAECs were visualized by
immunofluorescence labeling as described in the Methods. A. eNOS
immunofluorescence was associated with the plasmalemmal membrane (State A); B.
eNOS immunofluorescence was visualized in both the plasmalemmal membrane and the
cytosol (State B); C. eNOS immunofluorescence was visualized only in the cytosol
(State C).
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Figure 8. Effect of cocaine on eNOS distribution in bovine coronary artery
endothelial cells (BCAECs). Quantitative analysis of the cocaine-induced changes in
eNOS states. For each experiment, the image of cells taken under fluorescent
microscopy in 9 randomly selected high power fields were analyzed (approximately 200
cells/experiment). The proportion of each eNOS state as define in Fig. 7, the
plasmalemmal membrane (State A), both the plasmalemmal membrane and the cytosol
(State B), and the cytosol (State C) in cocaine-treated cells was normalized to that found
control cells. * P < 0.05 vs. the control.
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Figure 9. Effect of cocaine on eNOS protein levels in bovine coronary artery
endothelial cells (BCAECs). BCAECs were treated in the absence and presence of
cocaine (10, 30,100 pM) for 48 hr. Proteins were separated on 7.5% SDSpolyacrylamide gel, and eNOS was detected by Western blotting using a monoclonal
antibody. Actin was used as a loading control. The upper panel shows the representative
Western immunoblots. The lower panel shows the quantitative results. Data are
expressed as percent of the control levels for four independent experiments. * P < 0.05 vs.
the control.
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CHAPTER 6
SUMMARY
A. Cocaine Induces Endothelial Apoptosis
The preceding serial studies have been an in-depth look at the cellular and
molecular mechanisms of cocaine-induced apoptosis in coronary artery endothelial cells.
The studies in chapter two, demonstrated for the first time that cocaine causes a
direct cytotoxic effect on cultured human coronary artery endothelial cells (HCAECs) by
inducing the cells to apoptosis. The endothelial apoptosis was determined by multi
methods, which include cell morphological changes, phosphatidylserine extemalization,
nuclear morphological changes, in situ detection of fragmented DNA, and DNA ladder.
Similar studies were also denmonstrated in bovine coronary artery endothelial cells
(BCAECs). The qantitative analysis of apoptosis was performed by Hoechst nuclei
staining. Due to the fact that we only used the adherent cells in the qantification, we may
underestimate the number of apoptotic cells since certain percentage of the apoptotic cells
were dettached and was wash away. A more accurate alternative method can be used is
the flow cytometry which can differenciate apoptosis from necrosis and normal cells. Our
data suggest that cocaine-induced apoptosis in endothelial cells in a time- and dosedependent manner and is mediated by opioid receptors and is also calcium dependent.
Furthermore, the release of cytochrome c and its subsequent activation of caspase 9 and
caspase 3 are likely to play a key role in cocaine-induced apoptosis in HCAECs.
Our report, for the first time, links cocaine to coronary artery endothelial cells
apoptosis and provides evidence that cocaine-induced endothelial dysfunction may be
associated with endothelial apoptosis, which is likely to play a key role in cocaine-
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induced coronary artery vasoconstriction leading to myocardial ischemia and infarction.
In addition, phosphatidylserine is a potent surface procoagulant and it has been
demonstrated that human endothelial cells with phosphatidylserine extemalization during
apoptosis were markedly procoagulant (Casciola-Rosen et ah, 1996). Cocaine-induced
phosphatidylserine extemalization in coronary artery endothelial cells may cause
pathological intravascular coagulation events and impair coronary circulation, which may
also contribute in part to cocaine-induced myocardial ischemia and infarction.
The studies not only provide a basis to understand endothelium damage in
response to cocaine, but also improve our understanding of coronary ischemia, coronary
atherosclerosis, and myocardial infarction from a new prospective.
B. Role of Mitochondrial Apoptotic Pathway in Cocaine Induced Endothelial Apoptosis
The studies in chapter three further explored the mechanisms of cocaine-induced
apoptosis. We found that cocaine caused cell death of BCAECs through the
mitochondria-mediated apoptotic pathway. This conclusion is supported by the
following evidence: 1) cocaine-induced apoptosis was inhibited by cyclosporin A, 2)
cocaine caused translocation of cytochrome c from the mitochondria to the cytosol,
which was blocked by cyclosporin A, 3) cocaine-induced activation of caspase-9
preceded caspase-3, whereas caspase-8 was not activated.
The notion that cocaine activates the mitochondrial apoptotic pathway in
BCAECs has been further supported by the time course studies of cocaine-mediated
activation of caspase-9, caspase-8, and caspase-3 in the present study. The finding that
cocaine-mediated activation of caspase-9 preceded that of caspase-3 clearly demonstrated
that caspase-9 functions as an initiator caspase in cocaine-induced caspase cascade. The
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activation of caspase-9 by cytochrome c and apoptosis activating factor-1 (Apaf-1) has
been well documented (Green and Reed, 1998; Zou et ah, 1999). Whereas caspase-9 can
also be activated by caspase-8 through a death receptor-mediated pathway (Ashkenazi
and Dixit, 1998), the lack of effect of cocaine on caspase-8 precludes the potential
activation of caspase-9 by caspase-8 and suggests that death receptor/caspase-8 pathway
may not be involved in cocaine-induced apoptosis of BCAECs. In agreement with this
finding, the studies in chapter two demonstrated that cocaine-induced apoptosis of
coronary artery endothelial cells was inhibited by the inhibitors of caspase-9 and
caspase-3. Taken together, these findings demonstrate that cocaine-induced apoptosis in
coronary artery endothelial cells is mediated by the mitochondrial pathway, and the
release of cytochrome c and its subsequent activation of caspase-9 and caspase-3 play a
key role in cocaine-induced apoptosis.
C. Mechanisms of Cytochrome C Release in Cocaine-Induced Endothelial Apoptosis
In chapter three, we demonstrated that both Bcl-2 and Bax proteins were
expressed in BCAECs, with higher levels of the Bcl-2 protein. This is in contrast with
the previous findings in cultured cardiac myocytes isolated from near-term fetal rats,
which showed much lower content of Bcl-2 than that of Bax (Wang et al., 1998).
Nevertheless, a recent study demonstrated a developmental regulation of anti-apoptotic
and pro-apoptotic proteins in rat heart such that Bcl-2 and Bcl-xL levels were sustained
during development, but Bax and Bad levels were down-regulated (Cook et al., 1999).
The higher ratio of Bcl-2/Bax in adult cells may be associated with the withdrawal of
adult cells from the cell cycle in the perinatal period.
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The finding that Bcl-2 proteins decreased in response to cocaine suggests that the
Bcl-2 protein may play a key role in cocaine-induced apoptosis of BCAECs. In the
present study, we found that cocaine-induced decrease Bcl-2 protein level was partially
blocked by caspase-3 inhibitor Ac-DEVD-CHO. However, because cyclosporin A,
which blocked cocaine-induced cytochrome c release, had no effect on cocaine-induced
decrease in the Bcl-2 protein, it is likely that cocaine-induced decrease in Bcl-2 is an
upstream signal of cytochrome c release in BCAECs. The findings (chapter four) that the
cocaine-induced decrease in Bcl-2 proteins was partially blocked by caspases inhibitors in
the present study also suggests that the Bcl-2 protein is not only an upstream inhibitory
signal of caspases but also a downstream substrate of caspases. In chapter four we
reported that the activated caspases act as amplifiers in the positive feed back loop in
cocaine-induced apoptosis. The present finding suggests that exogenous NO may actually
promote Bcl-2 cleavage in endothelial cells. Indeed, it has been demonstrated in
neuronal cells that NO caused a decrease in Bcl-2 proteins (Matsuzaki et al., 1999;
Tamatani et al, 1998). However, because NO inhibited downstream caspase activation in
the present study, it blocked cocaine-induced apoptosis in BCAECs. We speculate that
cocaine-induced reduction of bcl-2 levels may be involved multiple mechanisms: 1)
caspases cleave bcl-2 protein which has been demonstrated in our experiments using
caspases inhibitors. 2) cocaine may directly or indirectly interact with the gene(s) that
regulate bcl-2 and caused a downregulation of bcl-2 protein expression. 3) cocaine may
decrease the stability of bcl-2 which can cause the degradation of the protein.
Unlike Bcl-2, cocaine did not change total Bax protein level. This is in contrast to
our previous findings in fetal rat heart and brain in which cocaine increases Bax
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expression (Xiao et al., 2000a; Xiao et al., 2000b). Similar findings were obtained in rat
heart after coronary occlusion (Liu et al., 1998) and cardiac myocytes exposed to
cytokines (Ing et al., 1999). However, the finding of no change in total Bax protein
levels does not necessarily preclude the potential role played by Bax in cocaine-induced
apoptosis in BCAECs. In contrast to Bcl-2, which is localized to the outer mitochondrial
membrane, Bax is predominantly present in the cytosol. Indeed, it has been well
documented that one of the crucial steps before Bax can exert its pro-apoptotic activity is
the translocation of Bax from the cytosol to the mitochondria and induction of
cytochrome c release. Bcl-2 exerts its anti-apoptotic activity partly by inhibiting the
translocation of Bax to the mitochondria (Murphy et al., 2000a; Murphy et al., 2000b;
Nomura et al., 1999). By down-regulating Bcl-2 levels in BCAECs, cocaine may
promote the translocation of Bax from the cytosol to the outer mitochondrial membrane.
leading to the release of cytochrome c. Our studies in chapter four demonstrated that
cocaine induced Bax translocation from cytosol to mitochondria suggests an important role
for Bax in cocaine-mediated apoptosis in BCAECs. Neither the caspase inhibitor nor NO
donor had an effect on cocaine-induced Bax translocation, suggesting that Bax is an
upstream signal of caspase activation, and NO-mediated inhibition of caspase activation
occurs downstream of Bax translocation.
D. Role of Nitric Oxide in Cocaine-Induced Endothelial Apoptosis
Although the molecular mechanisms underlying cocaine-mediated reduction of
Bcl-2 are not clear at present, we speculate that nitric oxide may be involved. We have
found that cocaine inhibits nitric oxide synthesis in BCAECs (chapters four and five).
Nitric oxide as a bifunctional regulator of apoptosis has been proposed recently (Kim et
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al., 1999). Depending on cell types and concentrations, nitric oxide can be a cytotoxic
effector in some cells, but a protector against apoptosis in other cells including
endothelial cells (Dimmeler et ah, 1997; Kim et ah, 1999). Studies have suggested that at
low concentrations NO mainly functions as an antiapoptotic molecule, although
excessive NO may induce cytotoxicity (Li and Billiar, 2000). It has been demonstrated
that nitric oxide maintains caspase-3 zymogen in an inactive form by S-nitrosylation of
the catalytic-site cysteine (Mannick et al., 1999), inhibits Bcl-2 cleavage by caspase-3,
and inhibits cytochrome c release (Kim et al., 1998; Kim et al., 1999).
Our finding (chapter four) that DETA-NO inhibited cocaine-induced apoptosis in
BCAECs is in agreement with previous results that exogenous NO protected endothelial
cells from apoptotic stimuli (Ceneviva et al., 1998; DeMeester et al., 1998; Ho et al.,
1999; Tzeng et al., 1997). Furthermore, the present results that the NO synthase inhibitor
L-NAME induced apoptotic cell death and decreased cell viability suggests that
endogenous NO is likely to play an important role in protecting BCAECs from apoptosis.
In a previous study, DeMeester et al. (1998) demonstrated that the NO synthase inhibitor,
N^-methyl-L-arginine did not affect lipopolysaccharide-induced apoptosis in pig aortic
endothelial cells, and concluded that endogenous NO did not inhibit endothelial cell
apoptosis. However, the direct effect of the NO synthase inhibitor on endothelial cell
apoptosis was not determined in their study (DeMeester et al., 1998). In the present
study, we found that cocaine inhibited NO release, and the decreased NO preceded
cocaine-induced apoptosis in BCAECs. Collectively, our data suggest that a reduction in
endogenous NO is likely to play an important role in cocaine-mediated cell death in
BCAECs. Nonetheless, the finding that L-NAME induces apoptosis to a less extent
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compared with cocaine suggests that decreased NO may not be the only mechanism by
which cocaine mediated apoptosis in BCAECs.
It is likely that multiple mechanisms are involved in NO-mediated antiapoptotic
effects. Previous studies demonstrated that NO reversibly inhibited seven members of the
caspase family via S-nitrosylation in hepatocytes (Li et ah, 1997). In the present study,
we demonstrated that cocaine-induced activation of caspase-3 and caspase-9 was blocked
by cyclosporin A, which inhibits cytochrome c release from mitochondria by stabilizing
mitochondrial transmembrane potential (Green and Reed, 1998). These results suggest
that cocaine-mediated cytochrome c release precede the activation of caspase-3 and
caspase-9. In addition, the present finding that cocaine-induced activation of caspase-3
was completely blocked by Z-LEHD-FMK, which blocked cocaine-induced caspase-9
activation, suggests that activation of caspase-9 precede caspase-3 in cocaine-stimulated
caspase cascade in BCAECs. This is further supported by the finding that the caspase-3
inhibitor Ac-DEVD-CHO only partially blocked cocaine-induced caspase-9 activation.
The fact that Ac-DEVD-CHO partially blocked caspase-9 activation suggests a positive
feedback of caspase-3 on the upstream caspase(s).
The present study clearly demonstrated that DETA-NO blocked cocaine-induced
activation of both caspase-3 and caspase-9 in BCAECs. It has been demonstrated that NO
maintains caspase-3 zymogen in an inactive form by S-nitrosylation of the catalytic-site
cysteine (Mannick et al., 1999; Rossig et al., 1999). Howerver, it is not clear at present
whether NO inhibits caspase-9 activity directly by S-nitrosylation or indirectly by
inhibiting the loss of mitochondrial inner transmembrane potential and cytochrome c
release. A recent study demonstrated that NO can also reversibly inhibited FTP opening
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and cytochrome c release at physiological levels of NO, while accelerated PTP opening at
pathophysiological NO levels (Brookes et ah, 2000). It is tempting to speculate that NOinhibited caspase activation induced by cocaine in the present study may be mediated by
both direct S-nitrosylation of caspases and indirect inhibition of cytochrome c release in
BCAECs. Given that caspase-9 is upstream of caspase-3 in the caspase cascade in
BCAECs, the possibility that DETA-NO-induced inhibition of caspase-3 was mediated in
part by its inhibition of caspase-9 cannot be ruled out in the present study.
Taken together, we speculate that cocaine exerts its cytotoxic effects on
endothelial cells through 3 mechanisms: 1) cleavage of Bcl-2, 2) induction of Bax
translocation, and 3) attenuation of NO production. Although the mechanisms underlying
cocaine-induced Bcl-2 cleavage in endothelial cells are not clear at present, decreased
Bcl-2 is likely to promote the translocation of Bax to the mitochondria, leading to the
release of cytochrome c and subsequent activation of the caspase cascade (Murphy et al.,
2000; Nomura et al.,1999; Putcha et al., 1999). Once the mitochondrial apoptotic pathway
is activated, the death signal is further amplified by the cleavage of Bcl-2 by the activated
caspases. This positive feedback loop ensures the cell’s demise. We speculate that NO
interacts with the mitochondria apoptotic pathway at two different levels: the
mitochondria level and the caspase level. By inhibiting mitochondrial PTP opening and
caspase activation, NO protects endothelial cells from apoptotic cell death. The finding
that Fas denitrosylates endogenous procaspase-3 which was normally S-nitrosylated by
endogenous NO (Mannick et al., 1999) suggests that NO-mediated S-nitrosylation of
procaspases may occur in the resting state as a mechanism to inhibit caspase activation.
Along with this finding, we speculate that cocaine-induced activation of caspases may be
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in part due to the denitrosylation of procaspases caused by the attenuation of NO. It
remains unclear whether cGMP plays a role in the antiapoptotic effect of NO.
Considering the multiple biological function of NO and its capacity of rapid diffuse
intracellularly and intercellularly, it is likely that the cytotoxicity of cocaine is far more
complicated in vivo and a variety of mechanisms may be involved.
E. Future Directions
The regulation of apoptosis in diseases is a fast-growing field and our current
knowledge might well be only scratching the surface of what awaits. Apoptosis is an
essential component of most developmental abnormalities and human diseases and, in
many cases, the underlying cause of the resulting pathology. The bcl-2 family proteins
are among the most studied molecules in the apoptotic pathways yet the precise
mechanisms by which they function as anti- or pro-apoptotic molecules remain unclear.
Regulating the expression of the bcl-2 family members is one of the most promising
therapeutic strategies in the treatment of diseases that are associated with apoptosis. For
cocaine-induced apoptosis, although we have shown cocaine decreases bcl-2 protein level
and induces bax translocation, there are still many questions remaining. For example:
What are the mechanisms of cocaine-induced decrease of bcl-2 level? At what level does
cocaine affect the decrease of bcl-2, pretranscriptional or posttranscriptional? How is bax
translocation regulated? What is the role of p53 in cocaine-induced reduction of bcl-2 and
bax translocation? Are there any other antiapoptotic bcl-2 family members such as bcl-xl,
bcl-w or proapoptotic bcl-2 family members such as bak or bad involved in cocaineinduced apoptosis? If so, what role do they play in the process and how do they interact
with bcl-2 and bax? Also, since we have known that nitric oxide inhibits
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cocaine-induced activation of caspases, does NO interact with the upstream signaling
such as the mitochondria membrane potential? Can NO inhibit cytochrome c release?
Why does NO play such a controversial role in different cell types? Although many
studies have been done in the past two decades, we still are mostly in the dark as to
molecular mechanisms of the cell death program. There is much work left to do. Cell
death will continue to be a lively field for the foreseeable future.
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